<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for childhood apraxia of speech - Morgan, AT - 2018 | Cochrane Library</title> <meta content="Interventions for childhood apraxia of speech - Morgan, AT - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for childhood apraxia of speech - Morgan, AT - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006278.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for childhood apraxia of speech" name="citation_title"/> <meta content="Angela T Morgan" name="citation_author"/> <meta content="angela.morgan@mcri.edu.au" name="citation_author_email"/> <meta content="Elizabeth Murray" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Frederique J Liégeois" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD006278.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006278.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Speech Therapy; *Speech‐Language Pathology; Apraxias [*therapy]; Speech Disorders [*therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006278.pub3&amp;doi=10.1002/14651858.CD006278.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="23LRTUA6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006278\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006278\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ru","fr","zh_HANT","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006278.pub3",title:"Interventions for childhood apraxia of speech",firstPublishedDate:"May 30, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006278.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006278.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006278.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006278.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006278.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006278.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006278.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006278.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006278.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006278.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>51032 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006278.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0093"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0074"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-sec-0087"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/appendices#CD006278-sec-0097"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for childhood apraxia of speech</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#CD006278-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Angela T Morgan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#CD006278-cr-0003">Elizabeth Murray</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information#CD006278-cr-0004">Frederique J Liégeois</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information/en#CD006278-sec-0140">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006278.pub3">https://doi.org/10.1002/14651858.CD006278.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006278-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006278-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006278-abs-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006278-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006278-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006278-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006278-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006278-abs-0001" lang="en"> <section id="CD006278-sec-0001"> <h3 class="title" id="CD006278-sec-0001">Background</h3> <p>Childhood apraxia of speech (CAS) affects a child's ability to produce sounds and syllables precisely and consistently, and to produce words and sentences with accuracy and correct speech rhythm. It is a rare condition, affecting only 0.1% of the general population. Consensus has been reached that three core features have diagnostic validity: (1) inconsistent error production on both consonants and vowels across repeated productions of syllables or words; (2) lengthened and impaired coarticulatory transitions between sounds and syllables; and (3) inappropriate prosody (ASHA 2007). A deficit in motor programming or planning is thought to underlie the condition. This means that children know what they would like to say but there is a breakdown in the ability to programme or plan the fine and rapid movements required to accurately produce speech. Children with CAS may also have impairments in one or more of the following areas: non‐speech oral motor function, dysarthria, language, phonological production impairment, phonemic awareness or metalinguistic skills and literacy, or combinations of these. High‐quality evidence from randomised controlled trials (RCTs) is lacking on interventions for CAS. </p> </section> <section id="CD006278-sec-0002"> <h3 class="title" id="CD006278-sec-0002">Objectives</h3> <p>To assess the efficacy of interventions targeting speech and language in children and adolescents with CAS as delivered by speech and language pathologists/therapists. </p> </section> <section id="CD006278-sec-0003"> <h3 class="title" id="CD006278-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, eight other databases and seven trial registers up to April 2017. We searched the reference lists of included reports and requested information on unpublished trials from authors of published studies and other experts as well as information groups in the areas of speech and language therapy/pathology and linguistics. </p> </section> <section id="CD006278-sec-0004"> <h3 class="title" id="CD006278-sec-0004">Selection criteria</h3> <p>RCTs and quasi‐RCTs of children aged 3 to 16 years with CAS diagnosed by a speech and language pathologist/therapist, grouped by treatment types. </p> </section> <section id="CD006278-sec-0005"> <h3 class="title" id="CD006278-sec-0005">Data collection and analysis</h3> <p>Two review authors (FL, AM) independently assessed titles and abstracts identified from the searches and obtained full‐text reports of all potentially relevant articles and assessed these for eligibility. The same two authors extracted data and conducted the 'Risk of bias' and GRADE assessments. One review author (EM) tabulated findings from excluded observational studies (<a href="http://01" target="_blank">Table 1</a>). </p> </section> <section id="CD006278-sec-0006"> <h3 class="title" id="CD006278-sec-0006">Main results</h3> <p>This review includes only one RCT, funded by the Australian Research Council; the University of Sydney International Development Fund; Douglas and Lola Douglas Scholarship on Child and Adolescent Health; Nadia Verrall Memorial Scholarship; and a James Kentley Memorial Fellowship. This study recruited 26 children aged 4 to 12 years, with mild to moderate CAS of unknown cause, and compared two interventions: the Nuffield Dyspraxia Programme‐3 (NDP‐3); and the Rapid Syllable Transitions Treatment (ReST). Children were allocated randomly to one of the two treatments. Treatments were delivered intensively in one‐hour sessions, four days a week for three weeks, in a university clinic in Australia. Speech pathology students delivered the treatments in the English language. Outcomes were assessed before therapy, immediately after therapy, at one month and four months post‐therapy. Our review looked at one‐month post‐therapy outcomes only. A number of cases in each cohort had recommenced usual treatment by their speech and language pathologist between one month and four months post‐treatment (NDP‐3: 9/13 participants; ReST: 9/13 participants). Hence, maintenance of treatment effects to four months post‐treatment could not be analysed without significant potential bias, and thus this time point was not included for further analysis in this review. </p> <p>We judged all core outcome domains to be low risk of bias. We downgraded the quality of the evidence by one level to moderate due to imprecision, given that only one RCT was identified. </p> <p>Both the NDP‐3 and ReST therapies demonstrated improvement at one month post‐treatment. For three outcomes the effect was marginally greater for NDP‐3 than ReST: accuracy of production on treated words (NDP‐3 mean difference (MD) = 36.0, ReST MD = 33.9; absolute MD = 2.1 between groups); speech production consistency, measured by 25 real words repeated three times using the inconsistency subtest of the Diagnostic Evaluation of Articulation and Phonology (DEAP) test (NDP‐3 MD = 11.1, ReST MD = 10.9; absolute MD = 0.2 between groups); and accuracy of connected speech, assessed by imitated word accuracy in connected speech of at least three word combinations (NDP‐3 MD = 14.3, ReST MD = 11.5; absolute MD = 2.8 between groups). ReST (MD = 18.3) demonstrated a marginally greater effect than NDP‐3 (MD = 18.2) for accuracy of production on non‐treated words at one month post‐treatment (absolute MD = 0.1 between groups). The study did not assess the outcome of functional communication. </p> </section> <section id="CD006278-sec-0007"> <h3 class="title" id="CD006278-sec-0007">Authors' conclusions</h3> <p>There is limited evidence that, when delivered intensively, both NDP‐3 and ReST may effect improvement in word accuracy in 4‐ to 12‐year‐old children with CAS, measured by the accuracy of production on treated and non‐treated words, speech production consistency and the accuracy of connected speech. The study did not measure functional communication. No formal analyses were conducted to compare NDP‐3 and ReST by the original study authors, hence one treatment cannot be reliably advocated over the other. We are also unable to say whether either treatment is better than no treatment or treatment as usual. No evidence currently exists to support the effectiveness of other treatments for children aged 4 to 12 years with idiopathic CAS without other comorbid neurodevelopmental disorders. Further RCTs replicating this study would strengthen the evidence base. Similarly, further RCTs are needed of other interventions, in other age ranges and populations with CAS and with co‐occurring disorders. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006278-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006278-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006278-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006278-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006278-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006278-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006278-abs-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006278-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006278-abs-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006278-abs-0012">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006278-abs-0006" lang="en"> <h3>One well‐controlled study shows some evidence of effect of two interventions for childhood apraxia of speech (CAS) </h3> <p><b>Review question</b><br/> What treatments help to improve the speech and language of children and adolescents with childhood apraxia of speech (CAS). </p> <p><b>Background</b><br/> Children with CAS find it difficult to produce sounds and syllables consistently and precisely in order to speak words and sentences with clarity and correct speech rhythm. As a result, children with CAS can be hard to understand with potential for negative impacts on school achievement and peer friendships. CAS affects around 0.1% of the general population. This review collates the research evidence to identify the most effective therapies for children with CAS. </p> <p><b>Search date</b><br/> The evidence is current to 6 April 2017. </p> <p><b>Study characteristics</b><br/> We found one study with 26 children aged 4 to 12 years with CAS. The children had mild to severe CAS without a known cause. Children were allocated randomly (using a method like coin tossing) to one of two treatments: the Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3); and the Rapid Syllable Transition treatment (ReST). Both therapies were delivered intensively in one‐hour sessions, four days a week for three weeks. The treatments were delivered by speech pathology students in a university clinic. Outcomes were assessed before therapy, immediately after therapy, at one month and four months post‐therapy. Our review looked at one‐month post‐therapy outcomes only. </p> <p><b>Study funding sources</b><br/> The included study was funded by the Australian Research Council; the University of Sydney International Development Fund; Douglas &amp; Lola Douglas Scholarship on Child and Adolescent Health; Nadia Verrall Memorial Scholarship; and a James Kentley Memorial Fellowship. </p> <p><b>Key results</b><br/> Further studies replicating these findings would strengthen available evidence. </p> <p>The study provides limited evidence that the NDP‐3 may improve the accuracy of production on treated items and the accuracy of connected speech. There is limited evidence that the NDP‐3 has a negligible effect on speech production consistency, and the ReST a negligible effect on accuracy of production on non‐treated words. The study did not measure functional communication. </p> <p><b>Quality of the evidence</b><br/> The included study was a randomised controlled trial with an overall low risk of bias. We downgraded the quality of the evidence by one level to moderate, due to imprecision, given that only one RCT was identified. </p> <p><b>Recommendations</b><br/> There is limited evidence that the NDP‐3 or ReST may be helpful for children with CAS of unknown origin, aged 4 to 12 years, without other co‐occurring conditions. We were not able to find out whether one of these treatment was better than the other, or whether either was better than no treatment or treatment as usual. There is currently no available evidence for other treatments. </p> <p>Further RCTs — including studies comparing treatments to a no‐treatment (wait‐list) control group — would strengthen the evidence base. Further research is also needed for children with CAS and other disorders or diagnoses. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006278-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006278-sec-0093"></div> <h3 class="title" id="CD006278-sec-0094">Implications for practice</h3> <section id="CD006278-sec-0094"> <p>The present review concluded that there is only one RCT examining interventions for CAS in the literature to date, which requires replication. This study provides some evidence that the NDP‐3 may improve the accuracy of production on treated items (words) and connected speech, but limited evidence that the NDP‐3 improves speech production consistency or that the ReST improves accuracy of production on non‐treated words. The study did not measure functional communication. </p> <p>There are a range of further therapies reported in the literature (<a href="#CD006278-tbl-0002">Table 1</a>), but the effectiveness of these interventions has not been rigorously examined; that is, other existing studies involve case study or case‐series investigations and not RCTs, limiting the ability to interpret and generalise findings to a broader population of children with CAS. At present the evidence supports the use of NDP‐3 or ReST intervention programmes for children with idiopathic CAS, aged 4 to 12 years, without other co‐occurring neurodevelopmental deficits. Further well‐controlled studies investigating the effectiveness of other treatments for CAS are urgently needed. There is a substantial range of treatments available for CAS; however, these require comparison with each other and to a no treatment (e.g. wait‐list control) group before their efficacy is rigorously demonstrated. Further trials are also needed that examine the efficacy of therapies for children with CAS with a range of co‐occurring neurodevelopmental impairments or diagnoses. </p> </section> <h3 class="title" id="CD006278-sec-0095">Implications for research</h3> <section id="CD006278-sec-0095"> <p>There is a critical need for further rigorously controlled studies of treatment efficacy for CAS. Replication of the work by <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> is required. Further work should also rigorously examine other CAS treatments reported in the literature. RCTs and quasi‐RCTs are difficult to conduct given the heterogeneity of presentation of individuals with CAS, and due to the low incidence of the disorder. However, the work of <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> shows RCTs are possible. </p> <p>Future studies may also investigate further therapy implementation variables to increase our understanding of treatment response in this population, in particular considering dose, delivery, uptake and context, with examples given below. </p> <p> <ol id="CD006278-list-0007"> <li> <p>Duration, dose, delivery, uptake and intensity of treatment (e.g. intervention once a week over 12 weeks or three sessions over five weeks) </p> </li> <li> <p>Response of particular subgroups of participants to treatment (e.g. subgroups based on age, genetic diagnosis, specific speech symptomatology), or dependent upon similarity of co‐occurring features (e.g. gross and fine motor or cognitive presentation) </p> </li> <li> <p>Impact of timing of treatment (e.g. intervention at three years versus six years)</p> </li> <li> <p>Effect of the administrator of treatment (e.g. clinician, parent, teacher's aide or even participant‐administered therapy for older children) </p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006278-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006278-sec-0043"></div> <div class="table" id="CD006278-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3) versus Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: children aged 4 to 12 years with CAS of unknown cause </p> <p><b>Settings</b>: University of Sydney Communication Disorders Treatment and Research Clinic </p> <p><b>Intervention</b>: NDP‐3 </p> <p><b>Comparison</b>: ReST </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Summary of MD findings</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Absolute MD</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b><i>Primary outcomes</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of production on treated items</b> </p> <p>Measured by: counting the number of real words produced correctly (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 36.0 was greater than the ReST MD of 33.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of production on non‐treated items</b> </p> <p>Measured by: counting the number of real words produced correctly (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ReST MD of 18.3 was minimally greater than the NDP‐3 MD of 18.2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b><i>Secondary outcomes</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Speech production consistency</b> </p> <p>Measured by: calculating the number of inconsistent productions of 25 words produced 3 times using the DEAP inconsistency subtest<sup>b</sup> </p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 11.1 was greater than the ReST MD of 10.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of connected speech</b> </p> <p>Measured by: counting the number of correct imitations of 3 word phrases (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 14.3 was greater than the ReST MD of 11.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>CAS</b> : childhood apraxia of speech; <b>DEAP</b> : Diagnostic Evaluation of Articulation and Phonology; <b>MD</b> : mean difference; <b>NDP‐3</b> : Nuffield Dyspraxia Programme ‐ Third Edition;<b>ReST</b>: Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the quality of evidence by one level, to moderate, for imprecision, as there was only one study for comparison.<br/> <sup>b</sup>Note, a decrease in inconsistency is a positive outcome. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006278-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006278-sec-0044"></div> <section id="CD006278-sec-0045"> <h3 class="title" id="CD006278-sec-0045">Description of the condition</h3> <p>Childhood apraxia of speech (CAS) affects a child's ability to produce speech sounds and syllables in the right order, and to speak words and sentences with accuracy and correct speech rhythm. Over sixty years ago, <a href="./references#CD006278-bbs2-0100" title="MorleyME , CourtD , MillerH . Developmental dysarthria. British Medical Journal1954;1(4852):8‐10. [PMC2093079] ">Morley 1954</a> provided a seminal paper documenting a series of speech characteristics in children that resembled the speech production disorder of adults with acquired apraxia of speech, and the diagnosis of CAS was born. CAS is a rare condition, affecting only around 0.1% of the general population (<a href="./references#CD006278-bbs2-0101" title="MorleyME . The Development and Disorders of Speech in Childhood. Baltimore (MD): Williams &amp; Wilkins Co., 1972. [ISBN 0443008957] ">Morley 1972</a>; <a href="./references#CD006278-bbs2-0115" title="YossKA . Developmental apraxia of speech in children: familial patterns and behavioral characteristics. American Speech and Hearing Association North Central Regional Conference, 1975 May 9; Minneapolis (MN). 1975. ">Yoss 1975</a>). CAS is more prevalent within particular medical subgroups, however, and particularly penetrant in certain genetic syndromes (e.g. <a href="./references#CD006278-bbs2-0081" title="FedorenkoE , MorganA , MurrayE , CardinauxA , MeiC , Tager‐FlusbergH , et al. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. European Journal of Human Genetics2016;24(2):302‐6. [DOI: 10.1038/ejhg.2015.149; PMC4717199; PUBMED: 26173965] ">Fedorenko 2016</a>; <a href="./references#CD006278-bbs2-0096" title="MeiC , FedorenkoE , AmorDJ , BoysA , HoeflinC , CarewP , et al. Speech and language phenotype in 16p11.2 deletion. European Journal of Human Genetics2017 (in press). ">Mei 2017</a>). </p> <p>Historically, synonyms such as verbal dyspraxia and developmental apraxia of speech have been used. The most commonly used terms today are CAS and developmental verbal dyspraxia (DVD), with the latter used largely in the UK context (<a href="./references#CD006278-bbs2-0104" title="Royal College of Speech and Language Therapists (RCSLT). Developmental verbal dyspraxia policy statement. www.rcslt.org/speech_and_language_therapy/rcslt_position_papers (accessed prior to 21 March 2018). ">RCSLT 2011</a>). We use the term CAS consistently throughout this review. </p> <p>A deficit in motor programming or planning is thought to underlie CAS; that is, children know what they would like to say but there is a breakdown in the ability to programme or plan the required movements to accurately produce speech. The current approach to diagnosis of CAS is expert‐based perception of speech symptoms (<a href="./references#CD006278-bbs2-0039" title="MaasE , ButallaCE , FarinellaKA . Feedback frequency in treatment for childhood apraxia of speech. American Journal of Speech‐language Pathology2012;21(3):239‐57. [DOI: 10.1044/1058‐0360(2012/11‐0119); PUBMED: 22442284] ">Maas 2012a</a>). There is consensus amongst speech and language pathologists (SLPs), also known as speech and language therapists (SLTs), that three core features of CAS have diagnostic validity: (1) inconsistent error production on both consonants and vowels across repeated productions of syllables or words; (2) lengthened and impaired coarticulatory transitions between sounds and syllables; and (3) inappropriate prosody (<a href="./references#CD006278-bbs2-0071" title="American Speech‐Language‐Hearing Association (ASHA). Technical Report. Childhood Apraxia of Speech: Ad Hoc Committee on Apraxia of Speech in Children. www.asha.org/policy/TR2007‐00278/ (accessed 20 April 2018). ">ASHA 2007</a>). </p> <p>In addition to the core features of CAS, children may also have co‐occurring impairments affecting non‐speech oral motor function, language, phonemic awareness/meta‐linguistics and literacy (<a href="./references#CD006278-bbs2-0071" title="American Speech‐Language‐Hearing Association (ASHA). Technical Report. Childhood Apraxia of Speech: Ad Hoc Committee on Apraxia of Speech in Children. www.asha.org/policy/TR2007‐00278/ (accessed 20 April 2018). ">ASHA 2007</a>). Younger children typically present with more severe forms of the disorder, with improvement noted over time for both idiopathic CAS (<a href="./references#CD006278-bbs2-0074" title="DavisBL , JacksA , MarquardtTP . Vowel patterns in developmental apraxia of speech: three longitudinal case studies. Clinical Linguistics and Phonetics2005;19(4):249‐74. [DOI: 10.1080/02699200410001695367; PUBMED: 16019775] ">Davis 2005</a>; <a href="./references#CD006278-bbs2-0088" title="JacksA , MarquardtTP , DavisBL . Consonant and syllable structure patterns in childhood apraxia of speech: developmental change in three children. Journal of Communication Disorders2006; Vol. 39, issue 6:424‐41. [DOI: 10.1016/j.jcomdis.2005.12.005] ">Jacks 2006</a>) and individuals with CAS associated with genetic syndromes (<a href="./references#CD006278-bbs2-0098" title="MorganA , FisherSE , SchefferIE , HildebrandM . FOXP2‐related speech and language disorders. 2016 Jun 23 [updated 2017 Feb 2]. In: AdamMP , ArdingerHH , PagonRA , WallaceSE , BeanLJH , StephensK , et al. editor(s). GeneReviews®. Seattle (WA): University of Washington, 1993‐2018. [www.ncbi.nlm.nih.gov/books/NBK368474/?report=reader#_NBK368474_pubdet_] ">Morgan 2017</a>; <a href="./references#CD006278-bbs2-0099" title="MorganAT , vanHaaftenL , vanHulstK , EdleyC , MeiC , Yang TanT , et al. Early speech development in Koolen de Vries Syndrome limited by oral praxis and hypotonia. European Journal of Human Genetics2018; Vol. 26, issue 1:75‐84. [DOI: 10.1038/s41431‐017‐0035‐9; PUBMED: 29225339] ">Morgan 2018</a>). It is not currently known how age, severity or underlying aetiology impact upon CAS treatment response or outcome. </p> <p>There are no epidemiological data on the prevalence of CAS, although it occurs infrequently in comparison with other forms of developmental speech disorder such as articulation disorder and phonological disorder, which occur in around 3.5% of preschool children (<a href="./references#CD006278-bbs2-0078" title="EadieP , MorganA , UkoumunneOC , Ttofari EecenK , WakeM , ReillyS . Speech sound disorder at 4 years: prevalence, comorbidities, and predictors in a community cohort of children. Developmental Medicine and Child Neurology2015;57(6):578‐84. [DOI: 10.1111/dmcn.12635; PUBMED: 25403868] ">Eadie 2015</a>). A population‐based estimate suggests that CAS occurs in one child per 1000 (0.1%) (<a href="./references#CD006278-bbs2-0101" title="MorleyME . The Development and Disorders of Speech in Childhood. Baltimore (MD): Williams &amp; Wilkins Co., 1972. [ISBN 0443008957] ">Morley 1972</a>; <a href="./references#CD006278-bbs2-0115" title="YossKA . Developmental apraxia of speech in children: familial patterns and behavioral characteristics. American Speech and Hearing Association North Central Regional Conference, 1975 May 9; Minneapolis (MN). 1975. ">Yoss 1975</a>), and is found in 3.4% to 4.3% of the children referred to clinics for speech disorder management (<a href="./references#CD006278-bbs2-0075" title="DelaneyAL , KentRD . Developmental profiles of children diagnosed with apraxia of speech. Annual Convention of the American Speech‐Language‐Hearing Association; 2004 Nov 18‐20; Philadelphia (PA). 2004. ">Delaney 2004</a>). The diagnosis of CAS can apply to children who have a specific impairment in speech with other neurodevelopmental functions relatively more preserved (e.g. borderline or typical non‐verbal cognition). Historically most cases were referred to as 'idiopathic', given limited aetiological knowledge of the condition (<a href="./references#CD006278-bbs2-0117" title="MorganAT , VogelAP . Intervention for childhood apraxia of speech. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD006278.pub2; PUBMED: 18646142] ">Morgan 2008</a>). In recent times, however, novel insights have been gained into the genetic and neurobiological bases of CAS (<a href="./references#CD006278-bbs2-0080" title="EisingE , Carrion‐CastilloA , VinoA , StrandEA , JakielskiKJ , ScerriTS , et al. A set of regulatory genes co‐expressed in embryonic human brain is implicated in disrupted speech development. Molecular Psychiatry 2018 Feb 20 [Epub ahead of print]. [DOI: 10.1038/s41380‐018‐0020‐x; PUBMED: 29463886] ">Eising 2018</a>). Variations in an increasing number of single genes have been associated with CAS (<a href="./references#CD006278-bbs2-0080" title="EisingE , Carrion‐CastilloA , VinoA , StrandEA , JakielskiKJ , ScerriTS , et al. A set of regulatory genes co‐expressed in embryonic human brain is implicated in disrupted speech development. Molecular Psychiatry 2018 Feb 20 [Epub ahead of print]. [DOI: 10.1038/s41380‐018‐0020‐x; PUBMED: 29463886] ">Eising 2018</a>; <a href="./references#CD006278-bbs2-0109" title="TurnerSJ , MayesAK , VerhoevenA , MandelstamSA , MorganAT , SchefferIE . GRIN2A: an aptly named gene for speech dysfunction. Neurology2015;84(6):586‐93. [DOI: 10.1212/WNL.0000000000001228; PMC4335991; PUBMED: 25596506] ">Turner 2015</a>), with the most replicated finding being disruption of the Forkhead box protein P2 or FOXP2 (<a href="./references#CD006278-bbs2-0089" title="LaiCS , FisherSE , HurstJA , Vargha‐KhademF , MonacoAP . A forkhead‐domain gene is mutated in a severe speech and language disorder. Nature2001;413(6855):519‐23. [DOI: 10.1038/35097076; PUBMED: 11586359] ">Lai 2001</a>; <a href="./references#CD006278-bbs2-0098" title="MorganA , FisherSE , SchefferIE , HildebrandM . FOXP2‐related speech and language disorders. 2016 Jun 23 [updated 2017 Feb 2]. In: AdamMP , ArdingerHH , PagonRA , WallaceSE , BeanLJH , StephensK , et al. editor(s). GeneReviews®. Seattle (WA): University of Washington, 1993‐2018. [www.ncbi.nlm.nih.gov/books/NBK368474/?report=reader#_NBK368474_pubdet_] ">Morgan 2017</a>; <a href="./references#CD006278-bbs2-0110" title="Vargha‐KhademF , GadianDG , CoppA , MishkinM . FOXP2 and the neuroanatomy of speech and language. Nature Reviews: Neuroscience2005;6(2):131‐8. [DOI: 10.1038/nrn1605; PUBMED: 15685218] ">Vargha‐Khadem 2005</a>). Beyond single gene causes, CAS has also been associated with copy number variant syndromes, such as 16p11.2 deletion syndrome (<a href="./references#CD006278-bbs2-0081" title="FedorenkoE , MorganA , MurrayE , CardinauxA , MeiC , Tager‐FlusbergH , et al. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. European Journal of Human Genetics2016;24(2):302‐6. [DOI: 10.1038/ejhg.2015.149; PMC4717199; PUBMED: 26173965] ">Fedorenko 2016</a>; <a href="./references#CD006278-bbs2-0096" title="MeiC , FedorenkoE , AmorDJ , BoysA , HoeflinC , CarewP , et al. Speech and language phenotype in 16p11.2 deletion. European Journal of Human Genetics2017 (in press). ">Mei 2017</a>), Koolen de Vries Syndrome (<a href="./references#CD006278-bbs2-0099" title="MorganAT , vanHaaftenL , vanHulstK , EdleyC , MeiC , Yang TanT , et al. Early speech development in Koolen de Vries Syndrome limited by oral praxis and hypotonia. European Journal of Human Genetics2018; Vol. 26, issue 1:75‐84. [DOI: 10.1038/s41431‐017‐0035‐9; PUBMED: 29225339] ">Morgan 2018</a>), 6q25.3 deletion syndrome (<a href="./references#CD006278-bbs2-0103" title="PeterB , LancasterH , VoseC , FaresA , SchrauwenI , HuentelmanM . Two unrelated children with overlapping 6q25.3 deletions, motor speech disorders, and language delays. American Journal of Medical Genetics. Part A2017;173(10):2659‐69. [DOI: 10.1002/ajmg.a.38385; PUBMED: 28767196] ">Peter 2017</a>), 7q11.23 duplication syndrome (<a href="./references#CD006278-bbs2-0111" title="VellemanSL , MervisCB . Children with 7q11.23 Duplication Syndrome: speech, language, cognitive, and behavioral characteristics and their implications for intervention. Perspectives on Language Learning and Education2011;18(3):108‐16. [DOI: 10.1044/lle18.3.108; PMC3383616; PUBMED: 22754604] ">Velleman 2011</a>), and other genetic conditions such as Floating Harbour syndrome (<a href="./references#CD006278-bbs2-0112" title="WhiteSM , MorganA , DaCostaA , LacombeD , KnightSJ , HoulstonR , et al. The phenotype of Floating‐Harbor syndrome in 10 patients. American Journal of Medical Genetics. Part A2010;152A(4):821‐9. [DOI: 10.1002/ajmg.a.33294; PUBMED: 20358590] ">White 2010</a>). Further to genetic causes, other medical conditions associated with CAS include metabolic disorders (e.g. galactosaemia; <a href="./references#CD006278-bbs2-0108" title="ShribergLD , PotterNL , StrandEA . Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia. Journal of Speech, Language, and Hearing Research2011;54(2):487‐519. [DOI: 10.1044/1092‐4388(2010/10‐0068); PMC3070858; PUBMED: 20966389] ">Shriberg 2011</a>) or epilepsy disorders (e.g. <a href="./references#CD006278-bbs2-0090" title="LiégeoisFJ , MorganAT . Neural bases of childhood speech disorders: lateralization and plasticity for speech functions during development. Neuroscience and Biobehavioral Reviews2012;36(1):439‐58. [DOI: 10.1016/j.neubiorev.2011.07.011; PUBMED: 21827785] ">Liégeois 2012</a>). In relation to neurobiology or brain function, there is inconsistency as regards the key brain regions and networks disrupted in CAS, with neuroimaging studies reporting both cortical and subcortical anomalies (<a href="./references#CD006278-bbs2-0090" title="LiégeoisFJ , MorganAT . Neural bases of childhood speech disorders: lateralization and plasticity for speech functions during development. Neuroscience and Biobehavioral Reviews2012;36(1):439‐58. [DOI: 10.1016/j.neubiorev.2011.07.011; PUBMED: 21827785] ">Liégeois 2012</a>; <a href="./references#CD006278-bbs2-0091" title="LiégeoisF , MayesA , MorganA . Neural correlates of developmental speech and language disorders: evidence from neuroimaging. Current Developmental Disorders Reports2014;1(3):215‐27. [DOI: 10.1007/s40474‐014‐0019‐1; PUBMED: PMC4104164] ">Liégeois 2014</a>; <a href="./references#CD006278-bbs2-0092" title="LiégeoisFJ , HildebrandMS , BonthroneA , TurnerSJ , SchefferIE , BahloM , et al. Early neuroimaging markers of FOXP2 intragenic deletion. Scientific Reports2016;6(35192):1‐9. [DOI: 10.1038/srep35192; PMC5062117; PUBMED: 27734906] ">Liégeois 2016</a>). </p> </section> <section id="CD006278-sec-0046"> <h3 class="title" id="CD006278-sec-0046">Description of the intervention</h3> <p>A range of CAS treatment approaches with differing theoretical standpoints have been reported. These studies are almost exclusively in the form of uncontrolled case studies or case series. Therapeutic approaches for CAS can be grouped into the following three areas. </p> <p> <ol id="CD006278-list-0001"> <li> <p><b>Motor‐based approaches</b>. These therapies are based on principles of motor learning (see <a href="./references#CD006278-bbs2-0093" title="MaasE , RobinDA , Austermann HulaSN , FreedmanSE , WulfG , BallardKJ , et al. Principles of motor learning in treatment of motor speech disorders. American Journal of Speech‐language Pathology2008;17(3):277‐98. [DOI: 10.1044/1058‐0360(2008/025); PUBMED: 18663111] ">Maas 2008</a> for a review); for example, traditional articulation‐based drill therapy (<a href="./references#CD006278-bbs2-0068" title="VellemanSL , StrandK . Developmental verbal dyspraxia. In: BernthalJE , BanksonNW editor(s). Child Phonology: Characteristics, Assessment, and Intervention with Special Populations. New York (NY): Thieme, 1994:110‐39. [ISBN 0‐86577‐502‐8] ">Velleman 1994</a>), the Nuffield Dyspraxia Programme (<a href="./references#CD006278-bbs2-0113" title="WilliamsP , StephensH , editor(s) . The Nuffield Centre Dyspraxia Programme. 3rd Edition. London (UK): The Nuffield Centre Dyspraxia Programme Ltd., 2004. [www.ndp3.org] ">Williams 2004</a>), the Rapid Syllable Transitions Treatment (<a href="./references#CD006278-bbs2-0003" title="BallardKJ , RobinDA , McCabeP , McDonaldJ . A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323] ">Ballard 2010</a>), rate control therapy (<a href="./references#CD006278-bbs2-0057" title="RosenthalJB . Rate control therapy for developmental apraxia of speech. Clinics in Communication Disorders1994;4(3):190‐200. [PUBMED: 7994294] ">Rosenthal 1994</a>), the PROMPT System (<b>P</b> rompts for <b>R</b> estructuring <b>O</b> ral <b>M</b> uscular<b>P</b> honetic <b>T</b>argets) (<a href="./references#CD006278-bbs2-0072" title="ChumpelikD . The PROMPT system of therapy: theoretical framework and applications for developmental apraxia of speech. Seminars in Speech and Language1984;5(2):139‐56. [DOI: 10.1055/s‐0028‐1085172] ">Chumpelik 1984</a>; <a href="./references#CD006278-bbs2-0014" title="DalePS , HaydenDA . Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. American Journal of Speech‐language Pathology2013;22(4):644‐61. [DOI: 10.1044/1058‐0360(2013/12‐0055); PUBMED: 23813194] ">Dale 2013</a>), melodic intonation therapy (<a href="./references#CD006278-bbs2-0026" title="Helfrich‐MillerKR . A clinical perspective: melodic intonation therapy for developmental apraxia. Clinics in Communication Disorders1994;4(3):175‐82. [PUBMED: 7994292] ">Helfrich‐Miller 1994</a>), adapted cueing technique (<a href="./references#CD006278-bbs2-0033" title="KlickSL . Adapted cuing technique for use in treatment of dyspraxia. Language, Speech, and Hearing Services in Schools1985;16:256‐9. [DOI: 10.1044/0161‐1461.1604.256] ">Klick 1985</a>), and integral stimulation or dynamic temporal and tactile cueing (<a href="./references#CD006278-bbs2-0039" title="MaasE , ButallaCE , FarinellaKA . Feedback frequency in treatment for childhood apraxia of speech. American Journal of Speech‐language Pathology2012;21(3):239‐57. [DOI: 10.1044/1058‐0360(2012/11‐0119); PUBMED: 22442284] ">Maas 2012a</a>; <a href="./references#CD006278-bbs2-0062" title="StrandEA , StoeckelR , BaasB . Treatment of severe childhood apraxia of speech: a treatment efficacy study. Journal of Medical Speech‐language Pathology2006;14(4):297‐307. [psycnet.apa.org/record/2006‐22884‐013] ">Strand 2006</a>). Motor‐based therapy can also include non‐speech oro‐motor techniques; for example, oral form recognition training (<a href="./references#CD006278-bbs2-0032" title="KingstonLM , RosenthalJB . Oral stereognosis in children with disordered articulation: measurement issues, and a treatment study. Australian Journal of Human Communication Disorders1987;15(1):1‐14. [DOI: 10.3109/asl2.1987.15.issue‐1.01] ">Kingston 1987</a>) and orofacial myofunctional therapy (<a href="./references#CD006278-bbs2-0054" title="RayJ . Effects of orofacial myofunctional therapy on speech intelligibility in individuals with persistent articulatory impairments. International Journal of Orofacial Myology2003;29:5‐14. [PUBMED: 14689652] ">Ray 2003</a>). Motor‐based therapy can also be instrumentally based, such as delayed auditory feedback (<a href="./references#CD006278-bbs2-0036" title="LozanoRA , DreyerDE . Some effects of delayed auditory feedback on dyspraxia of speech. Journal of Communication Disorders1978;11(5):407‐15. [PUBMED: 730833] ">Lozano 1978</a>), electropalatography (<a href="./references#CD006278-bbs2-0010" title="CarterP , EdwardsS . EPG therapy for children with long‐standing speech disorders: predictions and outcomes. Clinical Linguistics and Phonetics2004;18(6‐8):359‐72. [PUBMED: 15573477] ">Carter 2004</a>; <a href="./references#CD006278-bbs2-0038" title="LundeborgI , McAllisterA . Treatment with a combination of intra‐oral sensory stimulation and electropalatography in a child with severe developmental dyspraxia. Logopedics, Phoniatrics, Vocology2007;32(2):71‐9. [DOI: 10.1080/14015430600852035; PUBMED: 17613788] ">Lundeborg 2007</a>), and ultrasound (<a href="./references#CD006278-bbs2-0051" title="PrestonJL , BrickN , LandiN . Ultrasound biofeedback treatment for persisting childhood apraxia of speech. American Journal of Speech‐language Pathology2013;22(4):627‐43. [DOI: 10.1044/1058‐0360(2013/12‐0139); PUBMED: 23813207] ">Preston 2013</a>). </p> </li> <li> <p><b>Linguistic approaches</b>. Linguistic therapies address language impairments that can co‐occur in children with CAS. Examples of linguistic approaches include programmes to address phonological speech production or awareness (<a href="./references#CD006278-bbs2-0095" title="McNeillBC , GillonGT , DoddB . Effectiveness of an integrated phonological awareness approach for children with childhood apraxia of speech (CAS). Child Language Teaching and Therapy2009;25(3):341‐66. [DOI: 10.1177/0265659009339823] ">McNeill 2009</a>). </p> </li> <li> <p><b>Multi‐modal communication approaches</b>. These approaches seek to support verbal communication. Methods can address specific communication messages or features, such as Aided AAC (augmentative and alternative communication) Modelling (<a href="./references#CD006278-bbs2-0005" title="BingerC , LightJ . The effect of aided AAC modeling on the expression of multi‐symbol messages by preschoolers who use AAC. Augmentative and Alternative Communication2007;23(1):30‐43. [DOI: 10.1080/07434610600807470; PUBMED: 17364486] ">Binger 2007</a>), or use of technological devices (<a href="./references#CD006278-bbs2-0008" title="BornmanJ , AlantE , MeiringE . The use of a digital voice output device to facilitate language development in a child with developmental apraxia of speech: a case study. Disability and Rehabilitation2001;23(14):623‐34. [PUBMED: 11697460] ">Bornman 2001</a>; <a href="./references#CD006278-bbs2-0013" title="CumleyGD , SwansonS . Augmentative and alternative communication options for children with developmental apraxia of speech: three case studies. Augmentative and Alternative Communication1999;15(2):110‐25. [DOI: 10.1080/07434619912331278615] ">Cumley 1999</a>). </p> </li> </ol> </p> </section> <section id="CD006278-sec-0047"> <h3 class="title" id="CD006278-sec-0047">How the intervention might work</h3> <p>Below, we describe the ways in which the aforementioned approaches (described under <a href="#CD006278-sec-0046">Description of the intervention</a>) might work. </p> <p> <ol id="CD006278-list-0002"> <li> <p><b>Motor‐based approaches</b>. These methods use principles of motor learning, such as emphasizing a high number of successful repetitions of a task, using stimuli with high complexity, and a period of teaching followed by practice where cues and feedback are faded. Such approaches are reported to facilitate maintenance and generalisation in children with CAS (<a href="./references#CD006278-bbs2-0093" title="MaasE , RobinDA , Austermann HulaSN , FreedmanSE , WulfG , BallardKJ , et al. Principles of motor learning in treatment of motor speech disorders. American Journal of Speech‐language Pathology2008;17(3):277‐98. [DOI: 10.1044/1058‐0360(2008/025); PUBMED: 18663111] ">Maas 2008</a>; <a href="./references#CD006278-bbs2-0094" title="MaasE , Gildersleeve‐NeumannCE , JakielskiKJ , StoeckelR . Motor‐based intervention protocols in treatment of childhood apraxia of speech (CAS). Current Developmental Disorders Reports2014;1(3):197‐206. [DOI: 10.1007/s40474‐014‐0016‐4; PMC4192721; PUBMED: 25313348] ">Maas 2014</a>). </p> </li> <li> <p><b>Linguistic approaches</b>. These methods are focused on the semantics, phonology or grammar of language, and not on motor speech production per se. For example, a linguistic approach may include phonological contrast therapy, where children are taught how to abstract speech sound rules for the specific language(s) they speak (<a href="./references#CD006278-bbs2-0077" title="DoddB , CrosbieS , McIntoshB , HolmA , HarveyC , LiddyM , et al. The impact of selecting difference contrasts in phonological therapy. International Journal of Speech‐Language Pathology2008;10(5):334‐45. [DOI: 10.1080/14417040701732590; PUBMED: 20840033] ">Dodd 2008</a>). Another example of a linguistic approach is core vocabulary therapy, which focuses on shaping children's word approximations whilst expanding their expressive and receptive vocabulary (<a href="./references#CD006278-bbs2-0073" title="CrosbieS , HolmA , DoddB . Intervention for children with severe speech disorder: a comparison of two approaches. International Journal of Language and Communication Disorders2005;40(4):469‐71. [DOI: 10.1080/13682820500126049; PUBMED: 16195201] ">Crosbie 2005</a>). </p> </li> <li> <p><b>Multi‐modal communication approaches</b>. These methods are used for children who are minimally verbal to help them communicate and reduce the frustration associated with their speech disability. Devices may include a computer, phone or tablet with applications to help children produce words, phrases and sentences. Other methods involve gesture, sign language or use of visual picture boards. </p> </li> </ol> </p> </section> <section id="CD006278-sec-0048"> <h3 class="title" id="CD006278-sec-0048">Why it is important to do this review</h3> <p>There is a need for clinicians and parents to be aware of the most efficacious treatments for children with CAS. To date, studies in the field are largely non‐RCT (randomised controlled trials), single case series or case‐control studies that are generally positive in stating improvements in speech post‐therapy across motor (e.g. <a href="./references#CD006278-bbs2-0002" title="BaasBS , StrandEA , LMElmer , BarbaresiWJ . Treatment of severe childhood apraxia of speech in a 12‐year‐old male with CHARGE association. Journal of Medical Speech‐language Pathology2008;16(4):181‐90. ">Baas 2008</a>; <a href="./references#CD006278-bbs2-0003" title="BallardKJ , RobinDA , McCabeP , McDonaldJ . A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323] ">Ballard 2010</a>; <a href="./references#CD006278-bbs2-0017" title="EdealDM , Gildersleeve‐NeumannCE . The importance of production frequency in therapy for childhood apraxia of speech. American Journal of Speech‐language Pathology2011;20(2):95‐110. [DOI: 10.1044/1058‐0360(2011/09‐0005); PUBMED: 21330650] ">Edeal 2011</a>; <a href="./references#CD006278-bbs2-0021" title="HallPK . The occurrence of developmental apraxia of speech in a mild articulation disorder: a case study. Journal of Communication Disorders1989;22(4):265‐76. [PUBMED: 2794108] ">Hall 1989</a>; <a href="./references#CD006278-bbs2-0029" title="KadisDS , GoshulakD , NamasivayamA , PukonenM , KrollR , DeNilLF , et al. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topography2014;27(2):240‐7. [DOI: 10.1007/s10548‐013‐0308‐8; PMC3921462; PUBMED: 23974724] ">Kadis 2014</a>; <a href="./references#CD006278-bbs2-0043" title="McCabeP , Macdonald‐D'SilvaAG , vanReesLJ , BallardKJ , ArciuliJ . Orthographically sensitive treatment for dysprosody in children with childhood apraxia of speech using ReST intervention. Developmental Neurorehabilitation2014;17(2):137‐46. [DOI: 10.3109/17518423.2014.906002; PUBMED: 24694312] ">McCabe 2014</a>; <a href="./references#CD006278-bbs2-0061" title="StrandEA , DebertineP . The efficacy of integral stimulation intervention with developmental apraxia of speech. Journal of Medical Speech‐language Pathology2000;8(4):295‐300. [www.researchgate.net/publication/286964810_The_efficacy_of_integral_stimulation_intervention_with_developmental_apraxia_of_speech] ">Strand 2000</a>; <a href="./references#CD006278-bbs2-0062" title="StrandEA , StoeckelR , BaasB . Treatment of severe childhood apraxia of speech: a treatment efficacy study. Journal of Medical Speech‐language Pathology2006;14(4):297‐307. [psycnet.apa.org/record/2006‐22884‐013] ">Strand 2006</a>), linguistic (e.g. <a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a>; <a href="./references#CD006278-bbs2-0045" title="McNeillBC , GillonGT , DoddB . A longitudinal case study of the effects of an integrated phonological awareness program for identical twin boys with childhood apraxia of speech (CAS). International Journal of Speech‐language Pathology2009;11(6):482‐95. [DOI: 10.3109/17549500902842583; PUBMED: 21271925 ] ">McNeill 2009b</a>; <a href="./references#CD006278-bbs2-0046" title="McNeillBC , GillonGT , DoddB . The longer term effects of an integrated phonological awareness intervention for children with childhood apraxia of speech. Asia Pacific Journal of Speech, Language, and Hearing2010;13(3):145‐61. [DOI: 10.1179/136132810805335074] ">McNeill 2010</a>; <a href="./references#CD006278-bbs2-0060" title="StokesSF , GriffithsR . The use of facilitative vowel contexts in the treatment of post‐alveolar fronting: a case study. International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2010;45(3):368‐80. [DOI: 10.3109/13682820903094737; PUBMED: 20144008] ">Stokes 2010</a>; <a href="./references#CD006278-bbs2-0070" title="ZaretskyE , VellemanSL , CurroK . Through the magnifying glass: underlying literacy deficits and remediation potential in childhood apraxia of speech. International Journal of Speech‐language Pathology2010;12(1):58‐68. [PUBMED: 20380250] ">Zaretsky 2010</a>), and multi‐modal communication approaches (e.g. <a href="./references#CD006278-bbs2-0023" title="HarrisL , DoyleES , HaafR . Language treatment approach for users of AAC: experimental single‐subject investigation. Augmentative and Alternative Communication (Baltimore, Md. : 1985)1996;12(4):230‐43. [DOI: 10.1080/07434619612331277698] ">Harris 1996</a>; <a href="./references#CD006278-bbs2-0031" title="KingAM , HengstJA , DeThorneLS . Severe speech sound disorders: an integrated multimodal intervention. Language, Speech, and Hearing Services in Schools2013;44(2):195‐210. [DOI: 10.1044/0161‐1461(2012/12‐0023); PUBMED: 23633644] ">King 2013</a>; <a href="./references#CD006278-bbs2-0065" title="TierneyCD , PitterleK , KurtzM , NakhlaM , TodorowC . Bridging the gap between speech and language: using multimodal treatment in a child with apraxia. Pediatrics2016;138(3):e20160007. [DOI: 10.1542/peds.2016‐0007; PUBMED: 27492818] ">Tierney 2016</a>). Yet these non‐RCT studies are inherently biased in nature and there is a need in the field for a systematic evaluation of available evidence. This review identifies best available treatments for CAS. This is an update of a Cochrane Review first published in 2008 (<a href="./references#CD006278-bbs2-0117" title="MorganAT , VogelAP . Intervention for childhood apraxia of speech. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD006278.pub2; PUBMED: 18646142] ">Morgan 2008</a>). The previous review revealed no available RCTs for review. The first RCT in this field was published in 2015, hence it was timely to provide an updated review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006278-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006278-sec-0049"></div> <p>To assess the efficacy of interventions targeting speech and language in children and adolescents with CAS as delivered by speech and language pathologists/therapists. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006278-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006278-sec-0050"></div> <section id="CD006278-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006278-sec-0052"> <h4 class="title">Types of studies</h4> <p>RCTs and quasi‐RCTs (e.g. studies in which participants are allocated to intervention groups on alternate days). </p> </section> <section id="CD006278-sec-0053"> <h4 class="title">Types of participants</h4> <p>Children aged 3 to 16 years with a diagnosis of CAS made by a speech and language pathologist/therapist. </p> </section> <section id="CD006278-sec-0054"> <h4 class="title">Types of interventions</h4> <p>See <a href="#CD006278-sec-0046">Description of the intervention</a> section above. </p> <p>Eligible control groups were no treatment control (e.g. wait‐list control), treatment as usual, or other treatment controls. </p> </section> <section id="CD006278-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD006278-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006278-list-0003"> <li> <p>Accuracy of production on treated or non‐treated* items (may be associated with motor‐based, linguistic or multi‐modal communication approaches noted under <a href="#CD006278-sec-0047">How the intervention might work</a>) </p> </li> </ol> </p> <p>A desirable outcome would have been an improvement in accuracy of speech or multi‐modal communication, while an undesirable outcome would have been deterioration from baseline. </p> <p>*Non‐treated items are stimuli (e.g. syllables, words, phrases) that have not been practised by children during intervention sessions. They are a form of control whereby we are able to measure children's performance on 'treated' items (e.g. syllables, words, phrases the child has practised during speech sessions) and compare it with performance on 'non‐treated' items. In this way, we can quantify whether the child has 'generalised' their newly acquired speech skills, or improvement in speech, to non‐treated stimuli, or whether they have only improved on speech items practised during therapy. </p> </section> <section id="CD006278-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006278-list-0004"> <li> <p>Speech production consistency across repeated words and syllables (may be associated with motor‐based, linguistic or multi‐modal communication approaches noted under <a href="#CD006278-sec-0047">How the intervention might work</a>) </p> </li> <li> <p>Accuracy of connected speech, including co‐articulation accuracy (e.g. syllable segregation, voice onset time; most commonly associated with motor‐based or linguistic approaches noted under <a href="#CD006278-sec-0047">How the intervention might work</a>) </p> </li> <li> <p>Functional communication (e.g. child‐ or parent‐based questionnaire; may be associated with motor‐based, linguistic or multi‐modal communication approaches noted under <a href="#CD006278-sec-0047">How the intervention might work</a>) </p> </li> </ol> </p> <p>A desirable outcome would have been an improvement on outcomes one to three, whilst an undesirable outcome would have been deterioration from baseline on outcomes one to three. </p> <p>Outcome measurements were recorded before, immediately after and at longer‐term follow‐up.</p> </section> </section> </section> <section id="CD006278-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006278-sec-0059"> <h4 class="title">Electronic searches</h4> <p>Margaret Anderson, Cochrane Information Specialist for the Developmental, Psychosocial and Learning Problems Group, conducted the searches for this update in August 2011, June 2014 and April 2017. We searched the following list of sources which includes bibliographic databases, and international and national trials registers. We did not apply any date restrictions, but we only examined articles written in the English language. We report the search strategies for this update in <a href="./appendices#CD006278-sec-0098">Appendix 1</a>. Earlier search strategies are in <a href="./appendices#CD006278-sec-0119">Appendix 2</a>. </p> <p> <ol id="CD006278-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 3) in the Cochrane Library, and which includes the Cochrane Developmental, Psychosocial and Learning Problems Specialized Register (searched 6 April 2017) </p> </li> <li> <p>Ovid MEDLINE (1946 to March week 5 2017)</p> </li> <li> <p>Ovid MEDLINE E‐Pub Ahead of Print (searched 6 April 2017)</p> </li> <li> <p>Ovid MEDLINE In Process &amp; Other Non‐indexed Citations (searched 6 April 2017)</p> </li> <li> <p>Embase Ovid (1980 to 2017 week 15)</p> </li> <li> <p>CINAHL EBSCOhost (Cumulative Index to Nursing and Allied Health Literature; 1937 to 10 April 2017) </p> </li> <li> <p>PsycINFO Ovid (1806 to April week 1 2017)</p> </li> <li> <p>PsycINFO EBSCOhost (1887 to 4 August 2011)</p> </li> <li> <p>ERIC EBSCOhost (Education Resources Information Center; 1966 to 10 April 2017)</p> </li> <li> <p>ERIC Proquest (Education Resources Information Center; 1966 to 6 June 2014)</p> </li> <li> <p>C<i>ochrane Database of Systematic Reviews</i> (CDSR; 2017, Issue 4) part of the Cochrane Library </p> </li> <li> <p>Database of Abstracts of Reviews of Effect (DARE; 2015, Issue 2) part of the Cochrane Library (not searched in previous version of review (<a href="./references#CD006278-bbs2-0117" title="MorganAT , VogelAP . Intervention for childhood apraxia of speech. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD006278.pub2; PUBMED: 18646142] ">Morgan 2008</a>). Final issue published in 2015) </p> </li> <li> <p>SpeechBITE (<a href="http://speechbite.com/" target="_blank">speechbite.com</a>; searched 10 April 2017) </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (ANZCTR; <a href="http://www.anzctr.org.au/BasicSearch.aspx" target="_blank">www.anzctr.org.au/BasicSearch.aspx</a>; searched 12 April 2017) </p> </li> <li> <p>Chinese Clinical Trial Registry (ChiCTR; <a href="http://www.chictr.org.cn" target="_blank">www.chictr.org.cn</a>; searched 10 April 2017) </p> </li> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 10 April 2017) </p> </li> <li> <p>EU Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu" target="_blank">clinicaltrialsregister.eu</a>; searched 10 April 2017) </p> </li> <li> <p>ISRCTN Registry (<a href="http://www.isrctn.com" target="_blank">www.isrctn.com</a>; searched 10 April 2017) </p> </li> <li> <p>Nederlands Trial Register (<a href="http://www.trialregister.nl/trialreg/admin" target="_blank">trialregister.nl/trialreg/admin</a>; searched 10 April 2017) </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en</a>; searched 10 April 2017) </p> </li> </ol> </p> </section> <section id="CD006278-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of included reports, and requested information on unpublished trials from authors of published studies and other experts, as well as information groups in the areas of speech and language therapy/pathology and linguistics. </p> </section> </section> <section id="CD006278-sec-0061"> <h3 class="title" id="CD006278-sec-0061">Data collection and analysis</h3> <p>We were unable to use many of our preplanned methods (<a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>), as only one study met the inclusion criteria (<a href="#CD006278-sec-0051">Criteria for considering studies for this review</a>). This study was published in a peer‐reviewed journal and there are no other completed RCTs or quasi‐RCTs at this time, published or unpublished. See <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>. </p> <section id="CD006278-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Two review authors (FL and AM) independently screened all titles and abstracts yielded by the search for eligibility. In cases of uncertainty over whether an abstract met the inclusion criteria, we obtained the full‐text report. Next, the same two reviewers independently evaluated each full‐text report against the inclusion criteria (<a href="#CD006278-sec-0051">Criteria for considering studies for this review</a>). In the event of disagreement over inclusion of a particular paper, FL and AM reached consensus by re‐assessing the study against the inclusion criteria together. We present the results of our selection process in a PRISMA diagram; see <a href="#CD006278-fig-0001">Figure 1</a> (<a href="./references#CD006278-bbs2-0097" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097; PMC2707599; PUBMED: 19621072] ">Moher 2009</a>). </p> <div class="figure" id="CD006278-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD006278-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p> Study flow diagram</p> </div> </div> </div> </section> <section id="CD006278-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>In addition to outcome data, we documented the following information using a data management form: participant details; setting (e.g. community clinic, school); type of intervention; length and frequency of intervention; professions involved; duration of impairment; level of severity; co‐morbidity; and assessment tools employed. We requested any information that was missing or unclear from the corresponding author (<a href="#CD006278-sec-0067">Dealing with missing data</a>). AM independently extracted and entered the outcome data into Review Manager 5 (<a href="./references#CD006278-bbs2-0105" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and FL then independently evaluated the data and entries. AM and FL discussed any disagreements until they reached a consensus. EM entered further details of excluded studies into <a href="#CD006278-tbl-0002">Table 1</a>. </p> <div class="table" id="CD006278-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded, low‐quality evidence from observational studies (case‐series, case control)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methodology/paper type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention approach</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention intensity and duration</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Timing of outcome measures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methodological considerations</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0002" title="BaasBS , StrandEA , LMElmer , BarbaresiWJ . Treatment of severe childhood apraxia of speech in a 12‐year‐old male with CHARGE association. Journal of Medical Speech‐language Pathology2008;16(4):181‐90. ">Baas 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 12.8 years with CAS and charge syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phase I and II: sessions 4 × per week; Phase III: weekly therapy. Study over 25 months. Home practice not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy on 2‐item scale for treated items; speech rate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phase I (core vocabulary): change on 4/6 targets. Maintained at last probe.</p> <p>Phase II (core vocabulary): reached 100% accuracy for 3/5 words. Reduction of stereotypies.</p> <p>Phase III: decreased speech rate from 94 to 71 SPM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and during treatment. No longer‐term follow‐up data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines, control, longer‐term follow‐up or generalisation data. Clinical file data used. No replication across participants. Assessors, participants, therapists not blinded </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0003" title="BallardKJ , RobinDA , McCabeP , McDonaldJ . A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323] ">Ballard 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 siblings (2 males, 1 female) aged 7.8 and 10.10 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject multiple baseline design across behaviours and participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute sessions (100‐120 trials per session), 4 × per week for 12 sessions. Home practice not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reading aloud 10 treated and 10 non‐treated non‐word strings; real word generalisation data; perceptual analysis of prosodic pattern and acoustic analysis using pairwise variability index </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/3 had significant gains in treated items and generalisation to same level of treated complexity. 2/3 generalised to lower and higher complexity non‐word items. Minimal generalisation to real words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline data taken at beginning of every 4th session and at 4 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No long‐term follow‐up data. Limited participants for generalisation of outcomes. No blinding of assessors, participants or therapists. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0004" title="BeathardB , KroutRE . A music therapy clinical case study of a girl with childhood apraxia of speech: finding Lily's voice. Arts in Psychotherapy2008;35(2):107‐16. [DOI: 10.1016/j.aip.2008.01.004] ">Beathard 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 3 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Music therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other (alternative interventions)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions over 9 months. 24 sessions in total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Descriptive data only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commenced non‐verbal. At end, had 11 phonemes in inventory</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment and post‐treatment. No follow‐up data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No replicable outcome measures. No statistical analysis. No blinding of assessors, participants or therapists. No follow‐up or generalisation data. Unclear which aspect of treatment provided outcomes or affect of maturation, schooling, etc. No replication across participants. No long‐term follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0005" title="BingerC , LightJ . The effect of aided AAC modeling on the expression of multi‐symbol messages by preschoolers who use AAC. Augmentative and Alternative Communication2007;23(1):30‐43. [DOI: 10.1080/07434610600807470; PUBMED: 17364486] ">Binger 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 4.2 and 4.4 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of multi‐symbol messages in play scenarios</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of multi‐symbol messages using aided AAC as well as different types of messages. Maintained and generalised gains. Increased participation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. Limited outcome measures. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0006" title="BingerC , LightJ . The morphology and syntax of individuals who use AAC: research review and implications for effective practice. Augmentative and Alternative Communications2008;24(2):123‐38. [DOI: 10.1080/07434610701830587; PUBMED: 18465366] ">Binger 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female (Latino) aged 3.4 years with CAS and suspected velocardiofacial syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of multi‐symbol messages in play scenarios</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of multi‐symbol messages using aided AAC. Parental response to training excellent. Maintained and generalised gains </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0007" title="BingerC , Maguire‐MarshallM , Kent‐WalshJ . Using aided AAC models, recasts, and contrastive targets to teach grammatical morphemes to children who use AAC. Journal of Speech, Language, and Hearing Research2011;54(1):160‐76. [DOI: 10.1044/1092‐4388(2010/09‐0163); PUBMED: 20719874] ">Binger 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 6 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of grammatical morphemes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of grammatical morphemes using aided AAC. 2nd intervention period needed for 2/3 targets. Maintained gains </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every treatment session, and 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0008" title="BornmanJ , AlantE , MeiringE . The use of a digital voice output device to facilitate language development in a child with developmental apraxia of speech: a case study. Disability and Rehabilitation2001;23(14):623‐34. [PUBMED: 11697460] ">Bornman 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 6.6 years with CAS, hemiplegia and seizures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Voice output devices (Macaw)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute sessions for 2 sessions (training). Home practice focus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of appropriate responses to questions in structured discourse</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mother provided greater frequency and type of questions. Frequency of appropriate responses increased </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × baseline, 2 × practice period, 1 × post‐treatment, and 4 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data.<br/> CAS diagnosis unclear and not replicable. No statistical analysis.<br/> Limited outcome measures. No blinding of assessors. Unclear dosage of home practice. No generalisation data. No long‐term follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0010" title="CarterP , EdwardsS . EPG therapy for children with long‐standing speech disorders: predictions and outcomes. Clinical Linguistics and Phonetics2004;18(6‐8):359‐72. [PUBMED: 15573477] ">Carter 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male and 1 female aged 12 and 8 years respectively diagnosed with CAS. Additional 8 children (7 males) aged 4 to 7 years with persistent articulation errors </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series ‐ single group study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electropalatography (EPG) on /t, d, k, g, s, z/</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions, 1 × per week for 10 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent consonants correct (PCC) and Probe Scoring System (PSS) on probe of 43 words</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference noted for PSS for whole group. PCC scores improved in percentage</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment (baseline first session) and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up or generalisation data. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0012" title="CulpDM . Developmental apraxia and augmentative or alternative communication ‐ a case example. Augmentative and Alternative Communication1989;5(1):27‐34. [DOI: 10.1080/07434618912331274936] ">Culp 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 8 years with CAS and intellectual disability</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partners in Augmentative Communication Training (PACT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 to 90‐minute sessions daily after 3 days of intensive training. Home practice focus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ratio of parent vs participant messages; ratio of successful/intelligible messages from child </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant had greater frequency of messages compared to parent, and slightly higher frequency of successful measures (high baseline accuracy). Increased participation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment and 2 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0013" title="CumleyGD , SwansonS . Augmentative and alternative communication options for children with developmental apraxia of speech: three case studies. Augmentative and Alternative Communication1999;15(2):110‐25. [DOI: 10.1080/07434619912331278615] ">Cumley 1999</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 females and 1 male aged 3.4, 8 and 12.9 years respectively, with CAS (2 with intellectual disability and 1 with submucous cleft) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (3 case studies/reports)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined communication boards and voice output devices</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year‐old: 2 to 3 × per week for 12 weeks</p> <p>8‐year‐old: daily for 6 months</p> <p>12‐year‐old: not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year‐old: MLU.</p> <p>8‐year‐old: assessment of phonological processes; communication repairs.</p> <p>12‐year‐old: description of functional communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year old: minimal speech improvement, MLU increased to WNL</p> <p>8‐year old: no change in speech, parent report of greater communication repairs, and less frustration </p> <p>12‐year old: supplemented natural speech to initiate, maintain and repair communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐assessment and treatment descriptions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0014" title="DalePS , HaydenDA . Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. American Journal of Speech‐language Pathology2013;22(4):644‐61. [DOI: 10.1044/1058‐0360(2013/12‐0055); PUBMED: 23813194] ">Dale 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males and 1 female aged 3.6 to 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject (ABB or ABC) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT) ‐ full programme (FP) for 8 weeks versus PROMPT without tactile‐kinaesthetic‐proprioceptive cueing for 4 weeks and FP for 4 weeks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐minute session, 2 × per week for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained words on probe, untrained words. Pre‐post testing on the DEAP, TOCS+, VMPAC focal motor and sequencing subtests and Vineland socialization scales </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/4 improved on DEAP. 4/4 improved on TOCS+, VMPAC subtests and Vineland. All 4 showed greater improvement on easier targets and majority maintained to 3 months post‐treatment. Generalisation to untrained items noted </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe words: baseline × 3, treatment × 4, post‐treatment, and 3 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control as control data changed and interpreted as generalisation but no other control used (e.g. multiple baselines). CAS diagnosis concerning prosody unclear. Blinded assessors for only some outcomes. No withdrawal period between treatment phases and participant differences made comparison between conditions difficult. All measures not taken at consistent times </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0017" title="EdealDM , Gildersleeve‐NeumannCE . The importance of production frequency in therapy for childhood apraxia of speech. American Journal of Speech‐language Pathology2011;20(2):95‐110. [DOI: 10.1044/1058‐0360(2011/09‐0005); PUBMED: 21330650] ">Edeal 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 6.2 and 3.4 years with CAS (1 case with repaired cleft lip and palate and language disorder) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integral Stimulation (Dynamic Temporal and Tactile Cueing)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied across participants. 40‐minute sessions (15 minutes each condition plus probes). 1 case: 3 × per week for 11 weeks.<br/> 1 case: 2 × per week for 5 weeks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe data on targeted phonemes (articulation) in words for each participant. 1 phoneme targeted with high production frequency = 100 trials and another with moderate production frequency = 60 trials. Articulation and language sample taken at 2 weeks post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large effect sizes for high production frequency and moderate for moderate production frequency. Improvement in PCC and phoneme inventory post‐treatment. Some generalisation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, each treatment session, and 1 probe post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No long‐term follow‐up data. No blinding of assessors. Accuracy based on if target phoneme was correct (including cognate pair substitution) not if whole word was correct </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0021" title="HallPK . The occurrence of developmental apraxia of speech in a mild articulation disorder: a case study. Journal of Communication Disorders1989;22(4):265‐76. [PUBMED: 2794108] ">Hall 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 9 years with mild CAS (followed until 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study/report)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation therapy, motor‐programming remedial model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 school semesters</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Templin‐Darley Tests of Articulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remediation of all 31 items for /r/, /ɝ/ and /ɚ/</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Test completed each semester</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up data or generalisation data. No replication across participants. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0023" title="HarrisL , DoyleES , HaafR . Language treatment approach for users of AAC: experimental single‐subject investigation. Augmentative and Alternative Communication (Baltimore, Md. : 1985)1996;12(4):230‐43. [DOI: 10.1080/07434619612331277698] ">Harris 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 5 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Multiple baseline across discourse contexts)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer‐based AAC</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐minute sessions, 2 × per week for 22 sessions over 4 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of noun/verb phrases in reciprocal book reading and structured discourse</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in both contexts but more so in book reading than discourse. Some generalisation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline, treatment, and withdrawal probes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No follow‐up data. No blinding of assessors. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0026" title="Helfrich‐MillerKR . A clinical perspective: melodic intonation therapy for developmental apraxia. Clinics in Communication Disorders1994;4(3):175‐82. [PUBMED: 7994292] ">Helfrich‐Miller 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 2.9 to 8 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Melodic Intonation therapy (MIT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied. 37 to 71 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied. Description of skills, consonant inventories, sequencing error rates and intelligibility compared to typical development </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Child 1: all consonants in inventory</p> <p>Child 2: spoke in complex sentences, poor intelligibility, and articulation errors present. </p> <p>Child 3: sequencing error rate dropped from 75% to 22%. 13/18 consonant sounds improved</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No experimental control. Lack of information on diagnosis of CAS. Primarily descriptive measures ‒ not reliable or tested using statistics. No control, maintenance or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0027" title="IuzziniJ , ForrestK . Evaluation of a combined treatment approach for childhood apraxia of speech. Clinical Linguistics and Phonetics2010;24(4‐5):335‐45. [DOI: 10.3109/02699200903581083; PUBMED: 20345262] ">Iuzzini 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 3.7 to 6.10 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stimulability (STP) and modified Core Vocabulary (mCVT) used concurrently</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐minute sessions (10 minutes STP, 45 minutes mCVT), 2 × per week for 20 sessions. No home practice </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent phonemes correct, phonetic inventory and inconsistency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PCC increased on average 20% after combined therapy (range 9% to 32%). Inventory gained 5 phones on average (range 1 to 10). 3/4 had greater consistency on CSIP and ISP after therapy; 1 had greater inconsistency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor experimental control as stable baseline not established, lack of control data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No immediate post‐treatment data or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0028" title="JaromaM , DannerP , KoivuniemiE . Sensory integrative therapy and speech therapy for improving the perceptual motor skills and speech articulation of a dyspractic boy. Folia Phoniatrica1984;36(6):261‐6. [DOI: 10.1159/000265753] ">Jaroma 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 5.5 years with "some dyspraxic features" (CAS diagnosis not explicit)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory integrative therapy and speech therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily sessions for 2 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(SP only) Illinois Test of Psycholinguistic Abilities</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Test not completed post‐treatment. Observation of greater self‐monitoring and correction of speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures and no post‐treatment data.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants.<br/> Lack of information on speech therapy provided </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0029" title="KadisDS , GoshulakD , NamasivayamA , PukonenM , KrollR , DeNilLF , et al. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topography2014;27(2):240‐7. [DOI: 10.1007/s10548‐013‐0308‐8; PMC3921462; PUBMED: 23974724] ">Kadis 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 children (9 males, 5 females) aged 3 to 6 years with diagnosed CAS (compared to 14 age‐matched controls) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series pre‐post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × per week for 8 weeks (16 sessions in total)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2, HCAPP,</p> <p>VMPAC, MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains as a group for all speech measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐week pre‐treatment (baseline), 1‐week post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. Age‐matched control group older than CAS group. Limited information on PROMPT targets selected for replication. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0031" title="KingAM , HengstJA , DeThorneLS . Severe speech sound disorders: an integrated multimodal intervention. Language, Speech, and Hearing Services in Schools2013;44(2):195‐210. [DOI: 10.1044/0161‐1461(2012/12‐0023); PUBMED: 23633644] ">King 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males aged 4.1, 5.8 and 8.6 years diagnosed with CAS. 1 of the 3 diagnosed with Opitz FG syndrome and another with PDD‐NOS </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject multiple baseline across participants design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Multimodal Intervention (structured book reading, drill and play activities with AAC devices present and speech encouraged) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐hour sessions, 2 × per week for 3 to 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Category (e.g. vocalisation, AAC or both), type of word and accuracy targets.</p> <p>Case 1: final consonants.</p> <p>Case 2: initial /s/ clusters then /f/.</p> <p>Case 3: initial /s/ clusters</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increases in vocalisations/spoken speech noted for 3/3. Speech accuracy improved on targets for 1/3 cases but all showed some generalisation to more accurate everyday speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline probes, probes every 2nd treatment session, 1‐month post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor experimental control for case 1 and some change on control data noted. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No generalisation data. No long‐term treatment data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0033" title="KlickSL . Adapted cuing technique for use in treatment of dyspraxia. Language, Speech, and Hearing Services in Schools1985;16:256‐9. [DOI: 10.1044/0161‐1461.1604.256] ">Klick 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5.6 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adapted Cueing Technique</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 minutes of therapy per day for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of single words/utterances</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>From 2 to 4 words to 12 words and several carrier phrases. After 6 months began to produce novel sentences </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Description of progress during treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0034" title="KraussT , GallowayH . Melodic intonation therapy with language delayed apraxic children. Journal of Music Therapy1982;19(2):102‐13. [DOI: 10.1093/jmt/19.2.102] ">Krauss 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 5 and 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABAA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concurrent Melodic Intonation Therapy (MIT) and traditional therapy (20% and 80% of sessions respectively) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × per week over 2‐month period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment gains on word‐morpheme usage, auditory comprehension, naming, describing function, sentence completion, imitation of word phrases and articulation. Tested using language sampling and Porch Index of Communicative Ability in Children </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains were found in phrase length (MLU), picture naming, and verbal imitation tasks. Little change in articulation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment, post‐traditional therapy, and post‐MIT therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No long‐term follow‐up. There were no reliability data reported for language sample analysis, a subjective measure </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0035" title="LagasseB . Evaluation of melodic intonation therapy for developmental apraxia of speech. Music Therapy Perspectives2012;30(1):49‐55. [DOI: 10.1093/mtp/30.1.49] ">Lagasse 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 5 and 6 years with suspected CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Melodic Intonation Therapy (MIT) compared to 'traditional speech‐language therapy'</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing 1 × per week speech therapy (traditional articulation sessions) and 40‐minute MIT music sessions over 4 weeks (both treatments concurrent) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2; KLPA2 and speech production on stimulable sounds in 1‐ or 2‐syllable words</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case 1 made greater gains in MIT sessions (but only 2% gain). Case 2 made greater gains on traditional articulation therapy (15% gain) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0037" title="LükeC . Impact of speech‐generating devices on the language development of a child with childhood apraxia of speech: a case study. Disability and Rehabilitation. Assistive Technology2016;11(1):80‐8. [DOI: 10.3109/17483107.2014.913715; PUBMED: 24773213] ">Lüke 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 German‐speaking male aged 2.7 years with severe CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single case design (A‐B design with 3 follow‐up assessments post‐treatment with some treatment sessions between assessments) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speech Generating Devices ‒ fixed display (Gotalk 20+) and dynamic display (DynaVox V) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute sessions × 50 treatment sessions. Treatment sessions 2 to 28 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Means of communication (oral versus SGD), intelligibility of speech productions, consistency of speech productions, lexical development, and grammatical development </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more communication initially with SGD than speech; significant increase in speech intelligibility; consistency (however reduced data in baseline period); amount of words used; and increased MLU and inflections after 8 to 9 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of baseline data for consistency. CAS diagnosis unclear and not replicable. No blinding of assessors. No clear withdrawal phase after treatment with SGDs for control and no generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0038" title="LundeborgI , McAllisterA . Treatment with a combination of intra‐oral sensory stimulation and electropalatography in a child with severe developmental dyspraxia. Logopedics, Phoniatrics, Vocology2007;32(2):71‐9. [DOI: 10.1080/14015430600852035; PUBMED: 17613788] ">Lundeborg 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5.1 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case cross‐over design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐oral stimulation and electropalatography</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25‐minute sessions (5 minutes intra‐oral stim, 20 minutes EPG); daily at home, total of 195 sessions in 12 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent consonants correct, per cent phonemes correct, per cent words correct, intelligibility, visual deviancy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant treatment outcomes on all measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐testing, A1 (baseline), B (intervention: oral stimulation therapy), A2 (withdrawal for 3 months), B (intervention: EPG), and A3 (follow‐up) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over design, no control group or data taken to control for maturation. No replication across participants. No long‐term follow‐up or generalisation data taken </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0039" title="MaasE , ButallaCE , FarinellaKA . Feedback frequency in treatment for childhood apraxia of speech. American Journal of Speech‐language Pathology2012;21(3):239‐57. [DOI: 10.1044/1058‐0360(2012/11‐0119); PUBMED: 22442284] ">Maas 2012a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 5.4 to 8.4 years with CAS (2 also with dysarthria and a third with language disorder); 3 also in <a href="./references#CD006278-bbs2-0040" title="MaasE , FarinellaKA . Random versus blocked practice in treatment for childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2012;55(2):561‐78. [DOI: 10.1044/1092‐4388(2011/11‐0120); PUBMED: 22207698] ">Maas 2012b</a>, as below </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over<br/> 2 phases) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing (high versus moderate feedback frequency in cross‐over design) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐minute sessions 3 × per week for 3 participants but 1 had 60‐minute sessions 2 × per week </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of target words and phrases with 2 words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 responded better to low frequency feedback, 1 to high frequency feedback, and 1 to no condition. No generalisation effects </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Different doses across all participants. Treatment fidelity &lt; 80%. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0040" title="MaasE , FarinellaKA . Random versus blocked practice in treatment for childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2012;55(2):561‐78. [DOI: 10.1044/1092‐4388(2011/11‐0120); PUBMED: 22207698] ">Maas 2012b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males and 2 females) aged 5.0 to 7.9 years with CAS. 2 cases had additional dysarthria diagnoses. </p> <p>1 other case had multiple co‐occurring disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over<br/> 2 phases) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing (random versus blocked practice compared in cross‐over design) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 4 week blocks of therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of entire target words and phrases with 2 words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/4 responded to both conditions. 2 responded relatively better to blocked practice, 1 to random practice, and 1 to no condition. 2/4 demonstrated generalization </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Treatment fidelity &lt; 80%. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0041" title="MartikainenA‐L , KorpilahtiP . Intervention for childhood apraxia of speech: a single‐case study. Child Language Teaching and Therapy2011;27(1):9‐20. [DOI: 10.1177/0265659010369985] ">Martikainen 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 4.7 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Multiple baseline across behaviours ‐ cross‐over treatment design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined Melodic Intonation Therapy (MIT) and Touch Cue Method (TCM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor and linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sessions for 6 weeks for 18 sessions for MIT. 6 weeks no therapy. 3 sessions for 6 weeks for 18 sessions for TCM </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy: PVC, PCC. Also, overall word accuracy scores: PMLU, PWP, PWC.</p> <p>All calculated from responses to 46 picture cards</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/5 measures significant post‐MIT (per cent vowels correct). Per cent consonants correct also reduced. </p> <p>3/5 significant post‐TCM (PVC, PCC, PMLU).</p> <p>PVC, PCC and PMLU maintained.</p> <p>Greater changes for both therapies after withdrawal. PCC and PMLU only significant after MIT withdrawn </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beginning and end of 6‐week baseline, beginning and end of both treatment phases, 12 weeks after TCM withdrawn </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control of other factors. Cross‐over design makes comparison of both treatments difficult as many changes only noted after withdrawal of MIT (accumulation effects). Limited outcome data. Lack of generalisation data No blinded assessors. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0042" title="MartinMK , WrightLE , PerryS , CornettD , SchraederM , JohnsonJT . Children with developmental verbal dyspraxia: changes in articulation and perceived resilience with intensive multimodal intervention. Child Language Teaching and Therapy2016;32(3):261‐75. [DOI: 10.1177/0265659015615924] ">Martin 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (sex unknown) aged 3 to 10 years with CAS (11 with co‐occurring conditions)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series (pre and post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DuBard Association Method®. It is a multimodal, phonetic therapy which works from accurate sounds in isolation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily in small groups in a school programme for an 11‐month period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, mean length of utterance (MLU), and intelligibility on Arizona Articulation Proficiency<br/> Scale‐Third Revision (AAPS‐3) and perceptions of resilience judged by parents and SLPs </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant changes in articulation, intelligibility and MLU, and some resilience measures over 2‐year period </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control regarding maturation effects (despite using the Intervention Efficiency Index and Proportional Change Index) and lack of control of covariate, including other potential intervention over the same period. No control group. No follow‐up or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0043" title="McCabeP , Macdonald‐D'SilvaAG , vanReesLJ , BallardKJ , ArciuliJ . Orthographically sensitive treatment for dysprosody in children with childhood apraxia of speech using ReST intervention. Developmental Neurorehabilitation2014;17(2):137‐46. [DOI: 10.3109/17518423.2014.906002; PUBMED: 24694312] ">McCabe 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 males aged 5.5 to 8.6 years with CAS. 2 children had additional auditory processing impairments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design with 1 month follow‐up)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute session, 4 × per week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, prosodic and simultaneous articulation and prosodic accuracy on trained and untrained probe pseudo words; PCC, PVC and per cent lexical stress matches from connected speech; PPVT‐4 as control data </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All 4 participants increased perceptual accuracy. 1/4 participants showed change in untreated items. All participants showed change in prosody (average prosody gain 58%, 3/4 in PVC and 2/4 in PCC; average gain 79%). Control data (receptive vocabulary on PPVT‐IV) changed minimally </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 2, probes in treatment × 2, 1 month follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no immediate post‐treatment data taken to determine treatment effects, the follow‐up data was 1 month post‐treatment and included a withdrawal phase. There was no statistical analysis of connected speech data. 1 participant reached ceiling. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 4.2 to 7.6 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness Intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained speech accuracy and phonological awareness accuracy on a probe. Generalisation‐ BTOPP and first trial of DEAP inconsistency subtest for PVC, PVC and inconsistency score. PIPA for 4‐year‐olds. TOPA for 5 to 7‐year‐olds. Burt Word Reading Test for non‐word reading and informal non‐word reading probe (<a href="./references#CD006278-bbs2-0082" title="GillonGT . The efficacy of phonological awareness intervention for children with spoken language impairment. Language, Speech and Hearing Services in Schools2000;31(2):126‐41. [DOI: 10.1044/0161‐1461.3102.126; PUBMED: 27764385] ">Gillon 2000</a>). Per cent grapheme correct score in spelling 10 words from DEAP inconsistency subtest </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speech: 9/12 children improved on trained items. Phonological awareness: 8/12 children improved in 1 or both intervention blocks. Generalisation for 8/12 on all measures except Burt Word Reading Test </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0045" title="McNeillBC , GillonGT , DoddB . A longitudinal case study of the effects of an integrated phonological awareness program for identical twin boys with childhood apraxia of speech (CAS). International Journal of Speech‐language Pathology2009;11(6):482‐95. [DOI: 10.3109/17549500902842583; PUBMED: 21271925 ] ">McNeill 2009b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 male identical twins aged 4.5 years with CAS (deletion at 10q21.2‐22.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPC, PVC on BTOPP, and DEAP inconsistency percentage. PIPA, PhonRep, Burt Word Reading, Non‐word Reading, Neale accuracy and comprehension </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PCC and PVC improved at post‐treatment and follow‐up. Reduced inconsistency. Sound‐letter knowledge increased from 0 to 7 at post‐treatment. Reading WNL and spelling demonstrated use of strategies at final follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment, and 6‐month follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0046" title="McNeillBC , GillonGT , DoddB . The longer term effects of an integrated phonological awareness intervention for children with childhood apraxia of speech. Asia Pacific Journal of Speech, Language, and Hearing2010;13(3):145‐61. [DOI: 10.1179/136132810805335074] ">McNeill 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 4.2 to 7.6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (12‐month follow‐up to 2009 case series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As per <a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BBTOP and 1st trial of DEAP yielding PPC. PIPA for 4‐year‐olds &amp; TOPA for 5 to 7‐year‐olds. Decoding measures (Burt Word Reading Test and Non‐word Reading Task) and spelling measures (probe of 10 words from the DEAP inconsistency subtest) were completed for participants at least 6 years of age at the beginning of the study. The NARA was administered for participants aged 5 years, 6 months and up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference for CAS group from pre‐ to post‐treatment on letter knowledge, non‐word reading probe, spelling, PCC, TOPA and Burt Non‐Word Reading. 3/7 improved on NARA to age‐appropriate level </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐year follow‐up to <a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/12 of original participants followed up. Whole group data ‒ case series. No control group or control data for experimental control or maturation effects </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0048" title="MoriartyBC , GillonGT . Phonological awareness intervention for children with childhood apraxia of speech. International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2006;41(6):713‐34. [DOI: 10.1080/13682820600623960; PUBMED: 17079224] ">Moriarty 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 6.3, 6.10 and 7.3 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design across behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness Intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute sessions 3 × per week for 3 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPC on probe, phoneme segmentation probe, phoneme manipulation probes, initial sound identification probes, letter‒sound knowledge subtest from the PIPA, non‐word reading tasks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/3 significantly increased PPC, 2/3 significantly improved phonological awareness skills on probes, letter‒sound knowledge, and non‐word reading. Limited transfer to untreated words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and post‐treatment (3 probes each)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of control group and control data. CAS diagnosis unclear regarding prosody. Lack of multiple baseline data throughout treatment. No long‐term follow‐up. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0049" title="NamasivayamAK , PukonenM , GoshulakD , YuVY , KadisDS , KrollR , et al. Relationship between speech motor control and speech intelligibility in children with speech sound disorders. Journal of Communication Disorders2013;46(3):264‐80. [DOI: 10.1016/j.jcomdis.2013.02.003; PUBMED: 23628222] ">Namasivayam 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 3 to 6 years with speech sound disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series pre‐post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session 2 × per week for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2, HCAPP, VMPAC focal motor and sequencing subtests, Children's Speech Intelligibility Measure </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains as a group for all speech measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline 1 week prior to treatment, and 1 week post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group, multiple baseline or control data. No blinding of assessors. No blinding of assessors. No long‐term follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0050" title="NamasivayamA , PukonenM , HardJ , JahnkeR , KearneyE , KrollR , et al. Motor speech treatment protocol for developmental motor speech disorders. Developmental Neurorehabilitation2015;18(5):296‐303. [DOI: 10.3109/17518423.2013.832431; PUBMED: 24088085] ">Namasivayam 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 children (28 males, 9 females) aged 2.6 to 4.5 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (pre‐postgroup design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor Speech Treatment Protocol (MSTP)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intense treatment group: 45‐minute session, 2 × per week × 10 weeks = 20 sessions. Less intense group: 45‐minute session, 1 × per week × 10 weeks = 10 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA‐2 sounds in words subtest; speech intelligibility using Children's Speech Intelligibility Measure (CSIM) at word level, and Beginner's Intelligibility Test (BIT) at sentence level. Functional Outcomes for Children Under Six (FOCUS) scale </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intense group had greater changes in articulation and functional communication compared to the less intense group with large effect sizes. Mixed results were found for intelligibility: at word‐level (CSIM), both the less intense and 1/2 intense groups made a significant and large change. At sentence level, 1/2 intense groups made a significant change </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group or control data. Participants were not directly randomised; however, no between‐group differences were found at baseline. There were missing data (dealt with using intention‐to‐treat analysis). No information on session trials was obtained, which is important for intensity calculations </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0051" title="PrestonJL , BrickN , LandiN . Ultrasound biofeedback treatment for persisting childhood apraxia of speech. American Journal of Speech‐language Pathology2013;22(4):627‐43. [DOI: 10.1044/1058‐0360(2013/12‐0139); PUBMED: 23813207] ">Preston 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 males aged 9 to 15 years with CAS. 1 child had additional ADHD and another child had additional dysarthria </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (targeting articulation on clusters and CV or VC sequences of inaccurate phones) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 minute sessions, 2 × per week × 18 sessions (at least 150 trials per session)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe of whole‐word accuracy of treated and untreated items</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>U002 and U007 had significant gains on 2/4 treated combinations, U005 for 3/4, and U008, U009 and U012 had significant gains on all treated combinations. All exhibited some generalisation (target‐dependant). U005, U007, U008, U009, U012 demonstrated maintenance above pre‐treatment levels </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probes at baseline × 3, every treatment session, post‐treatment, and 2 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group or comparison treatment. No blinding of assessors. Untreated items were not clearly selected as control or generalisation data with some showing change and others not </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0052" title="PrestonJL , LeeceMC , MaasE . Intensive treatment with ultrasound visual feedback for speech sound errors in childhood apraxia. Frontiers in Human Neuroscience2016;10:440. [DOI: 10.3389/fnhum.2016.00440; PMC5003919; PUBMED: 27625603] ">Preston 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 male children aged 11 to 13 years diagnosed with CAS and poor expressive language and phonological processing. 1 participant had additional flaccid dysarthria, ADHD, language and learning difficulties </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours (syllable positions))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (using structured chaining and principles of motor learning)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 hour sessions × 14 sessions. Sessions 1 to 7 addressed target 1 and sessions 8 to 14 addressed target 2 with randomly assigned prosody or no prosody conditions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment acquisition data, generalisation probe of untreated words, maintenance to 2 months post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/3 participants acquired accurate articulation. 0/3 demonstrated generalisation or maintenance </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 × baseline probes, midway therapy probe, post‐therapy probe (within 1 week after treatment), and 2‐month follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group. Greater within‐treatment probes and post‐treatment probes would have allowed for greater statistical analysis. No control data. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0053" title="PrestonJL , LeeceMC , MaasE . Motor‐based treatment with and without ultrasound feedback for residual speech‐sound errors. International Journal of Language and Communication Disorders2017;52(1):80‐94. [DOI: 10.1111/1460‐6984.12259; PMC5156595; PUBMED: 27296780] ">Preston 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males aged 11 to 14 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi/RCT</p> <p>(Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (using structured chaining and principles of motor learning.)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (Instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 1‐hour articulation treatment a day for 2 weeks. 16 hours of therapy in total. Over 100 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment acquisition of /ɹ/, /s/ or /ʧ/. Generalisation to untrained items using a probe and sentence imitation task, and maintenance 1 to 3 weeks post‐treatment (audio‐samples submitted) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case 1 had acquisition, generalisation, and maintenance of targets. Case 2 had some acquisition in the 2nd week of therapy and no generalisation and maintenance. Case 3 showed acquisition, limited generalisation to words and not phrases, and no maintenance </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe conducted 1 × before treatment, at the end of the first week, and at the end of the second week (post‐treatment) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No blinding of assessors. No long‐term follow‐up data. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0054" title="RayJ . Effects of orofacial myofunctional therapy on speech intelligibility in individuals with persistent articulatory impairments. International Journal of Orofacial Myology2003;29:5‐14. [PUBMED: 14689652] ">Ray 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 adult with CAS and class III malocclusion. Another 5 adults aged 18 to 23 years with persistent articulation disorders </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orofacial myofunctional therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (Instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session, 1 × per week for 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dworkin‐Culatta Oral Mechanism Examination for oral postures and intelligibility in single words, sentences, and spontaneous speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All improved lips and tongue postures. 5/6 participants increased intelligibility. No improvement in intelligibility for person with DVD </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No treatment data or follow‐up reported. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0056" title="RosenbekJ , HansenR , BaughmanCH , LemmeM . Treatment of developmental apraxia of speech: a case study. Language, Speech, and Hearing Services in Schools1974;5:13‐22. [DOI: 10.1044/0161‐1461.0501.13] ">Rosenbek 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 9 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intensive, systematic drill motor therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 sessions over 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐item probe of /r/ (target), ineligibility in spontaneous speech</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/r/ improved from 0 to 20 correct in probe. Intelligibility judged by unfamilar listeners improved </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up data. Only ancedotal generalisation data. No statistical analysis. No reliability of judgments reported. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0057" title="RosenthalJB . Rate control therapy for developmental apraxia of speech. Clinics in Communication Disorders1994;4(3):190‐200. [PUBMED: 7994294] ">Rosenthal 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (3 males, 1 female) aged 10‐14 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject (ABAB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate Control Therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐minute session per reading passage. No further information available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy (words read correctly)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improved to 85% accuracy at 50% habitual rate and maintained in therapy as rate was slowly increased. Limited generalisation to conversation ‐ therapy implemented </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reading rate in 5‐minute intervals</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of control and follow‐up data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No stimulus generalisation measures. No report of data reliability </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0058" title="SkeltonSL , HagopianAL . Using randomized variable practice in the treatment of childhood apraxia of speech. American Journal of Speech‐language Pathology2014;23(4):599‐611. [DOI: 10.1044/2014_AJSLP‐12‐0169; MEDLINE: 25017177] ">Skelton 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 4 to 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concurrent treatment (using randomised variable practice)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Therapy until target sounds reached 80% accuracy. P1 had 26, P2 had 12 and P3 had 28 sessions. 2 × per week, 30 minutes per session and on average 100 to 115 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent correct productions on /s, z, f, v/ trained targets during baseline and treatment; generalisation probes to untrained words and 3‐word phrases </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children reached 80% accuracy on target sounds. Moderate to large generalisation effects at word and 3‐word phrases levels (70% to 100% accuracy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 × baseline probes, probes every 5 therapy sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No post‐treatment or follow‐up/maintenance data. No blinded assessors. No stimulus generalisation data. P3 continued regular school therapy during the study so could be a confounding factor. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0060" title="StokesSF , GriffithsR . The use of facilitative vowel contexts in the treatment of post‐alveolar fronting: a case study. International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2010;45(3):368‐80. [DOI: 10.3109/13682820903094737; PUBMED: 20144008] ">Stokes 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 7 years with residual CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation with facilitative vowel contexts</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐ to 55‐minute session, 3 × per week for 3 weeks. 60+ trials per session. Home practice provided </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on 'sh' sound in word initial probe, 'tr' as control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement in 'sh' articulation accuracy in trained and untrained words. No change in control words with 'tr' initial </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment, mid‐therapy × 2 (after sessions 3 and 6), post‐treatment, and maintenance (2 weeks post‐treatment) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant did not meet current CAS criteria. Lack of generalisation data beyond 'sh' sound. No blinded assessors. No replication across participants. No long‐term follow‐up data. No reliability of data reported </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0061" title="StrandEA , DebertineP . The efficacy of integral stimulation intervention with developmental apraxia of speech. Journal of Medical Speech‐language Pathology2000;8(4):295‐300. [www.researchgate.net/publication/286964810_The_efficacy_of_integral_stimulation_intervention_with_developmental_apraxia_of_speech] ">Strand 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5 years with "severe motor planning deficits but no dysarthria" (CAS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integral stimulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐ to 50‐minute session, 3 to 5 × per week (1 to 2 × per day) for 10 to 16 sessions. No home practice </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy ratings on a 2‐point scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement from 0.25 to 0.80 on 2‐point scale. 4/5 treatment stimuli achieved rating of 2/2 by end of therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treated stimuli at start of each session, control stimuli twice a week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0062" title="StrandEA , StoeckelR , BaasB . Treatment of severe childhood apraxia of speech: a treatment efficacy study. Journal of Medical Speech‐language Pathology2006;14(4):297‐307. [psycnet.apa.org/record/2006‐22884‐013] ">Strand 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 males aged 5.5 to 6.1 years with CAS (2 with dysarthria and 1 with mild intellectual disability) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions, 2 × per day for 5 days a week for 38 to 50 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy on a 3‐point scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment gains for 3/4 participants maintained by 2/4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 4 (or more, staggered baseline), 20+ treatment probes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No follow‐up or generalisation data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0063" title="ThomasDC , McCabeP , BallardKJ . Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech: the effect of lower dose‐frequency. Journal of Communication Disorders2014;51:29‐42. [DOI: 10.1016/j.jcomdis.2014.06.004; PUBMED: 25052390] ">Thomas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 4.8 to 8 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants and behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 minute sessions 2 × per week for 6 weeks. 100 trials per session</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on imitated (a) treated words, (b) untreated pseudo words, (c) untreated real words and control words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement on treated words and untreated real words. Significant improvement for 2/4 participants on untreated pseudo words. No change in control items </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3 to 6, treatment × 3, and 1 day, 1 month and 4 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use of GFTA2 for control items. No stimulus generalisation data</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0064" title="ThomasDC , McCabeP , BallardKJ , LincolnM . Telehealth delivery of Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech. International Journal of Language &amp; Communication Disorders2016;51(6):654‐71. [DOI: 10.1111/1460‐6984.12238; PUBMED: 27161038] ">Thomas 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 children (4 males, 1 female) aged 5 to 11 years with CAS (3 with mild or moderate receptive language disorder) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT<br/> (Single case multiple baseline across participants) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based ‐ telehealth)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute session, 4 times a week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on treated pseud‐word items, generalisation to untreated non‐words and real words, and control items (articulation of rhotics) on a probe; client/family satisfaction with telehealth treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/5 participants demonstrated significant change in treated items. 4/5 maintained gains to 4 months post‐treatment. 4/5 had significant generalisation to untrained non‐words and real words, and 1/5 demonstrated change in control data (articulation errors of rhotics or /s/). Families very satisfied and motivated by telehealth treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 3 baseline probes, 3 therapy probes (sessions 5, 9 and 1 day post‐treatment). Follow‐up at 1 week, 4 weeks &amp; 4 months post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Missing data for some participants at certain time points in Table 3. Problems with change in control data. Some internet issues (dropouts, port sound quality, etc.) were observed in 61% of sessions; however, significant outcomes were found. No stimulus generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0065" title="TierneyCD , PitterleK , KurtzM , NakhlaM , TodorowC . Bridging the gap between speech and language: using multimodal treatment in a child with apraxia. Pediatrics2016;138(3):e20160007. [DOI: 10.1542/peds.2016‐0007; PUBMED: 27492818] ">Tierney 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 3 years with CAS and fine motor delay</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT</p> <p>(Single case design; descriptive)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multimodal therapy: Signed Exact English sign language, Sarah Rosenfeld Johnson's oro‐motor programme and Kaufman Speech Praxis Program </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic‐based sessions 45 minutes 1 to 2 × per week and home‐based sessions for 60 minutes 1 × per week </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Language assessment; observations and Kaufman Speech Praxis Test; Verbal Motor<br/> Production Assessment for Children (VMPAC) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receptive and expressive language consistently in average range but receptive relatively better than expressive language. By 3.6 years of age receptive and expressive language same level. Marked drooling and limited inventory and sequencing at 18 months, yet skills on Kaufman &amp; VMPAC in average range at 3 years, 9 months. Discharged from therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Language assessment at 1.1 year, 3 years and 3.6 years. Kaufman test or observations at 1.6, 3 and 3.9 years. VMPAC at 3 years, 9 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable regarding prosody and drooling. No statistical analysis.<br/> No blinding of assessors. No replication across participants. Limited repeated measures on same instrument. Participant had multiple therapies concurrently </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0066" title="VashdiE . Using VML (verbal motor learning) method techniques in treatment of prosody disorder due to childhood apraxia of speech: a case study. International Journal of Child Health and Human Development2013;6(2):255‐60. [www.novapublishers.com/catalog/product_info.php?products_id=52658] ">Vashdi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 14 years with severe CAS and limb/motor apraxia and obsessive compulsive disorder </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Verbal Motor Learning (with Dynamic Distal Stabilization Technique (DDST))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 × 30‐minute clinic session and 6 × home practice sessions a week for 4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(1) Producing highest pitch using /I/ sound with and without DDST, to determine minimum and maximum frequency and length using Speech Analyser 1.5 </p> <p>(2) Imitation of 18 words to analyse word length, maximum loudness, maximum and minimum frequency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant t‐test results for (1) increase in maximum frequency and length of pitch after DDST, no change in minimum frequency, and (2) decrease in word length (word said faster), maximum loudness, and maximum frequency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Unclear data analysis procedures (unclear if they used visual analysis or perceptual analysis, and if they tested assumptions for the statistical analysis completed) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0067" title="VashdiE . The influence of initial phoneme cue technique on word formation: a case study of a child with apraxia of speech and autism. International Journal of Child Health and Human Development2014;7(2):197‐203. [www.novapublishers.com/catalog/product_info.php?products_id=53974] ">Vashdi 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 10 years with CAS and ASD</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Verbal Motor Learning (Initial Phoneme Cue (IPC) technique)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 1 hour sessions, 2 weeks apart (participant had initial therapy: 1‐hour session weekly for 1 year prior to this study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imitation accuracy of CVCV treated words either (a) with IPC or (b) without IPC</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imitation of CVCV was 0% to 22% accuracy and imitation with IPC was 96% to 100% accuracy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No statistical analysis. No blinding of assessors. No follow‐up or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0069" title="YossKA , DarleyFL . Developmental apraxia of speech in children with defective articulation. Journal of Speech and Hearing Research1974;17(3):399‐416. [PUBMED: 4421901] ">Yoss 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 children (no information on gender reported) aged 6 to 11 years with moderate to severe DAS </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case descriptions/file audit)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>School‐based intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 to 307 hours of therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, polysyllable words and connected speech in speech samples. Intelligibility rated on a 9‐point scale </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement on articulation. Minimal generalisation to polysyllable words and connected speech. Intelligibility improved by at least 0.5 points </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis.<br/> No blinding of assessors. No follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0070" title="ZaretskyE , VellemanSL , CurroK . Through the magnifying glass: underlying literacy deficits and remediation potential in childhood apraxia of speech. International Journal of Speech‐language Pathology2010;12(1):58‐68. [PUBMED: 20380250] ">Zaretsky 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 11.6 years with CAS, intellectual disability and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phonological awareness (phoneme‒grapheme mapping, reading comprehension, 'Basics' programme). Speech ‐ PROMPT and Moving Across Syllables </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Between 6.0 and 11.6 ongoing weekly treatments ‐ 1 hour × 1:1 sessions and PROMPT institute over summer </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on phonological awareness and decoding</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement seen in phoneme‒grapheme mapping, segmentation and short vowel identification. Some improvement in decoding </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing 1 × per week sessions from 6.0 to 11.6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Difficult to replicate measures and treatment used </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Participants: All participants are English speakers unless otherwise reported.</p> <p><b>AOS</b> : apraxia of speech; <b>BBTOP</b> : Bankson‐Bernthal Test of Phonology; <b>CAS</b> : childhood apraxia of speech; <b>CSIP</b> : consonant substitute inconsistency percentage; <b>DAS</b> : developmental apraxia of speech; <b>DEAP</b> : Diagnostic Evaluation of Articulation and Phonology; <b>DVD</b> : developmental verbal dyspraxia; <b>GDD</b> : global developmental delay; <b>GFTA‐2</b> : Goldman Fristoe Test of Articulation 2; <b>HCAPP</b> : Hodson Computerized Analysis of Phonological Patterns; <b>ISP</b> : inconsistency severity percentage; <b>KLPA‐2</b> : Khan‐Lewis Phonological Analysis, Second Edition; <b>NARA</b> : Neale Analysis of Reading Ability; <b>PCC</b> : percentage consonants correct; <b>PDD‐NOS</b> : pervasive developmental disorder ‐ not otherwise specified; <b>PMLU</b> : phonological mean length of utterance; <b>PVC</b> : percentage vowels correct; <b>PWC</b> : percentage words correct; <b>PWP</b> : proportion of whole‐word proximity; <b>PIPA</b> : Preschool and Primary Inventory of Phonological Awareness; <b>RCT</b> : randomised control trial; <b>SSD</b> : speech sound disorder; <b>TOCS+</b> : Test of Children's Speech Plus; <b>TOPA</b> : Test of Phonological Awareness; <b>VMPAC</b>: Verbal Motor Production Assessment for Children </p> </div> </div> </section> <section id="CD006278-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (FL and AM) independently assessed the risk of bias within the one included study, using Cochrane's 'Risk of bias' tool (<a href="./references#CD006278-bbs2-0086" title="HigginsJP , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [DOI: 10.1136/bmj.d5928; PMC3196245; PUBMED: 22008217] ">Higgins 2011a</a>). Both review authors rated the risk of bias as low, high or unclear (uncertain), across each of the domains listed below. There were no cases of disagreement. </p> <p> <ol id="CD006278-list-0006"> <li> <p><b>Sequence generation</b>. Did the study describe the method used to generate the allocation sequence in sufficient detail to determine whether it produced comparable groups? In the review authors' judgment, was the sequence adequately generated? </p> </li> <li> <p><b>Allocation concealment</b>. Did the study describe the method used to conceal the allocation sequence in sufficient detail to assess whether intervention schedules could have been foreseen in advance of, or during, recruitment? In the review authors' judgment, was allocation adequately concealed? </p> </li> <li> <p><b>Blinding of participants and personnel</b>. Did the study describe any measures used to blind participants and personnel from knowledge of which intervention a given participant might have received? In the review authors' judgment, was knowledge of the allocated interventions adequately concealed from participants and relevant personnel during the study? </p> </li> <li> <p><b>Blinding of outcome assessment</b>. Did the study describe any measures used to blind outcome assessors from knowledge of which intervention a given participant might have received? In the review authors' judgment, was knowledge of the allocated interventions adequately concealed from all outcome assessors during the study? </p> </li> <li> <p><b>Incomplete outcome data</b>. Did the study report data on attrition and exclusions as well as the numbers involved (compared with total randomised), reasons for attrition/exclusion, and any re‐inclusions in analyses performed. In the review authors' judgment, did the study authors deal adequately with incomplete data? </p> </li> <li> <p><b>Selective outcome reporting</b>. Did the study make attempts to assess the possibility of selective outcome reporting? In the review authors' judgment, are reports of the study free of suggestion of selective outcome reporting determined by comparing the outcomes listed in the original study protocol with the final RCT publication? </p> </li> <li> <p><b>Other sources of bias</b>. Was the study apparently free of other problems that could put it at a high risk of bias? In the review authors' judgement, was the study free of other problems not covered by the domains above? </p> </li> </ol> </p> </section> <section id="CD006278-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>We were unable to conduct a meta‐analysis due to there being only one included study. We have archived our methods for use in future updates of this review (see <a href="./appendices#CD006278-sec-0127">Appendix 3</a>; <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>). </p> </section> <section id="CD006278-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <p>For each outcome measure, we averaged the accuracy of production (e.g. number of correct items from total items elicited) across the group. Units were mean accuracy scores for each intervention group. See <a href="./appendices#CD006278-sec-0127">Appendix 3</a> for additional methods archived for use in future updates of this review. </p> </section> <section id="CD006278-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>There were missing data for 1/26 participants in the <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> RCT, due to a participant withdrawing in the middle of treatment (see <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>). </p> </section> <section id="CD006278-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We were unable to assess heterogeneity as only one study met the inclusion criteria (see <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>). </p> </section> <section id="CD006278-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>We were unable to assess reporting biases due to there being only one included study (see <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>). </p> </section> <section id="CD006278-sec-0070"> <h4 class="title">Data synthesis</h4> <p>We could not undertake a meta‐analysis as we included only one study in the review (see <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>). </p> <section id="CD006278-sec-0071"> <h5 class="title">Summary of findings</h5> <p>Using GRADEpro GDT (<a href="./references#CD006278-bbs2-0085" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 30 April 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>), we created a 'Summary of findings' table for the comparison: Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3) versus Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech. In this table we report our primary (accuracy of production on treated and non‐treated items) and secondary (speech production consistency and accuracy of connected speech) outcomes for one month post‐treatment. We chose this time point as it is the most clinically salient time point. The time point immediately after therapy is not sufficient to determine whether the treatment effect was sustained. We did not examine the time point of four months post‐therapy because the number of participants in each group (NDP‐3: 9/13 participants; ReST: 9/13 participants) had returned to community SLP/SLT treatment between the one‐month and four‐month post‐therapy period and, as such, it would be difficult to delineate between a sustained treatment effect of the RCT versus the usual therapy re‐introduced. We also report in this table the quality ratings for each outcome as assessed by two review authors (AM and FL) using the GRADE approach (<a href="./references#CD006278-bbs2-0106" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , AklE , et al. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017</a>). They assigned ratings of high, moderate, low or very low quality, according to the presence of risk of bias (<a href="#CD006278-sec-0079">Risk of bias in included studies</a>), indirectness of evidence, unexplained heterogeneity or inconsistency in results, imprecision of results and high probability of publication bias; they discussed any disagreements over the quality ratings until a consensus was reached. </p> <p>Please see '<a href="./full#CD006278-tbl-0001">summary of findings Table for the main comparison</a>' for an overview of treatment effects for each outcome measure and GRADE assessment of the quality of the evidence. </p> </section> </section> <section id="CD006278-sec-0072"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were unable to perform any subgroup analyses as we included only one study in the review. See <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>. </p> </section> <section id="CD006278-sec-0073"> <h4 class="title">Sensitivity analysis</h4> <p>We were unable to perform a sensitivity analysis as we included only one study in the review. See <a href="./appendices#CD006278-sec-0127">Appendix 3</a> and <a href="./references#CD006278-bbs2-0116" title="MorganA , VogelA . Intervention for developmental apraxia of speech. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD006278] ">Morgan 2006</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006278-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006278-sec-0074"></div> <section id="CD006278-sec-0075"> <h3 class="title">Description of studies</h3> <section id="CD006278-sec-0076"> <h4 class="title">Results of the search</h4> <p>We identified a total of 7978 records once duplicates were discarded. EM identified a further 16 records through handsearching. Of these 7994 titles and abstracts, we excluded 7895 as clearly irrelevant, and assessed the full texts of the remaining 99 reports against our inclusion criteria (<a href="#CD006278-sec-0051">Criteria for considering studies for this review</a>). From these 99 reports, only one study met our inclusion criteria for this review (<a href="#CD006278-sec-0077">Included studies</a>); we excluded the remaining 98 reports as irrelevant (see <a href="#CD006278-sec-0078">Excluded studies</a>). We did not identify any non‐English abstracts for inclusion. Please see <a href="#CD006278-fig-0001">Figure 1</a>. </p> </section> <section id="CD006278-sec-0077"> <h4 class="title">Included studies</h4> <p>The one included study, <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a>, was an RCT that compared treatment effects for two interventions, each delivered intensively (one hour for four days a week for three weeks): the Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3; <a href="./references#CD006278-bbs2-0113" title="WilliamsP , StephensH , editor(s) . The Nuffield Centre Dyspraxia Programme. 3rd Edition. London (UK): The Nuffield Centre Dyspraxia Programme Ltd., 2004. [www.ndp3.org] ">Williams 2004</a>) and the Rapid Syllable Transition treatment (ReST; <a href="./references#CD006278-bbs2-0003" title="BallardKJ , RobinDA , McCabeP , McDonaldJ . A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323] ">Ballard 2010</a>). Twenty‐six children (13 allocated to each therapy group), aged 4 to 12 years (18 males) with CAS diagnosed by a SLP/SLT participated in the study, which took place at the University of Sydney Communication Disorders Treatment and Research Clinic. The primary outcomes were per cent accuracy on treated and untreated pseudo‐words and real words and phrases. </p> <p>The research was funded (as published in the article) by: Douglas and Lola Douglas Scholarship on Child and Adolescent Health; Nadia Verrall Memorial 2010; and Postgraduate Student Scholarship 2011 through Speech Pathology Australia, James Kentley Memorial Scholarship, Postgraduate Research Support Schemes and Faculty of Health Sciences; University of Sydney International Development Program Fund, and the Australian Research Council Future Fellowship. </p> <p>Please see the <a href="./references#CD006278-sec-0148" title="">Characteristics of included studies</a> table for further detail of the nature of these interventions. </p> </section> <section id="CD006278-sec-0078"> <h4 class="title">Excluded studies</h4> <p>We excluded 98 full‐text reports. Of these, 29 studies were either not interventions (e.g. diagnostic studies), or did not include participants with CAS (e.g. focused on other speech disorders or adult‐acquired apraxia of speech). The remaining 69 excluded papers were CAS intervention studies but were not RCTs, and are tabulated in <a href="./references#CD006278-sec-0149" title="">Characteristics of excluded studies</a> tables. Further detail on the excluded CAS studies is provided in <a href="#CD006278-tbl-0002">Table 1</a>. </p> </section> </section> <section id="CD006278-sec-0079"> <h3 class="title">Risk of bias in included studies</h3> <p>We examined the one included study, <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a>, for risk of bias. We judged the study to be at low risk of bias for all domains except 'other sources of bias', which we judged to be at unclear risk of bias. Please see the 'Risk of bias' table (beneath the <a href="./references#CD006278-sec-0148" title="">Characteristics of included studies</a> table) for further detail on the basis of our decisions, and <a href="#CD006278-fig-0002">Figure 2</a> for a summary of ratings. </p> <div class="figure" id="CD006278-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006278-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD006278-sec-0080"> <h3 class="title" id="CD006278-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD006278-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>We downgraded the quality of the evidence by one level to moderate due to imprecision, given that only one RCT was identified. </p> <section id="CD006278-sec-0081"> <h4 class="title">Primary outcome: accuracy of production</h4> <p>The <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> study compared the number of real words produced correctly (out of the total elicited words) at pre‐treatment with one month post‐treatment for treated and non‐treated items. </p> <section id="CD006278-sec-0082"> <h5 class="title">Treated items</h5> <p>The study authors reported that, compared to pre‐treatment baseline, the NDP‐3 MD of 36.0 was greater than the ReST MD of 33.9 at one month post‐treatment, with an absolute mean difference of 2.1 between groups. </p> </section> <section id="CD006278-sec-0083"> <h5 class="title">Non‐treated items</h5> <p>The study authors reported that, compared to pre‐treatment baseline, the ReST MD of 18.3 was minimally greater than the NDP‐3 MD of 18.2 at one month post‐treatment with an absolute mean difference of 0.1 between groups. </p> </section> </section> <section id="CD006278-sec-0084"> <h4 class="title">Secondary outcomes</h4> <section id="CD006278-sec-0085"> <h5 class="title">Speech production consistency</h5> <p>The <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> study compared treatment gains in speech production consistency (measured by 25 real words repeated three times using the inconsistency subtest of the Diagnostic Evaluation of Articulation and Phonology (DEAP) test (<a href="./references#CD006278-bbs2-0076" title="DoddB , HuaZ , CrosbieS , HolmA , OzanneA . DEAP: Diagnostic Evaluation of Articulation and Phonology. San Antonio (TX): PsychCorp of Harcourt Assessment, 2006. ">Dodd 2006</a>)), at pre‐treatment with one month post‐treatment for treated items. The study authors reported that, compared to pre‐treatment baseline, the NDP‐3 MD of 11.1 was minimally greater than the ReST MD of 10.9 at one month post‐treatment, with an absolute mean difference of 0.2 between groups. </p> </section> <section id="CD006278-sec-0086"> <h5 class="title">Accuracy of connected speech</h5> <p>The <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a> study compared treatment gains in the accuracy of connected speech (as assessed by imitated word accuracy in connected speech of at least three word combinations), at pre‐treatment with one month post‐treatment for treated items. The study authors reported that, compared to pre‐treatment baseline, the NDP‐3 MD of 14.3 was greater than the ReST MD of 11.5 at one month post‐treatment, with an absolute mean difference of 2.8 between groups. </p> <p>The study did not measure functional communication.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006278-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006278-sec-0087"></div> <section id="CD006278-sec-0088"> <h3 class="title" id="CD006278-sec-0088">Summary of main results</h3> <p>We sought to investigate the effectiveness of targeted speech and language interventions for children and young people, aged 3 to 16 years of age, with a diagnosis of CAS made by a speech and language pathologist/therapist. We found only one study, <a href="./references#CD006278-bbs2-0001" title="MurrayE , McCabeP , BallardKJ . A randomized controlled trial for children with childhood apraxia of speech comparing rapid syllable transition treatment and the Nuffield Dyspraxia Programme ‐Third Edition. Journal of Speech, Language, and Hearing Research2015;58(3):669‐86. [DOI: 10.1044/2015_JSLHR‐S‐13‐0179; PUBMED: 25807891] Murray E. (Faculty of Health Sciences, The University of Sydney, Lidcombe , Australia) . [personal communication]. Conversation with: A Morgan (Murdoch Children's Research Institute, Melbourne, Australia) 13 August 2015. ">Murray 2015</a>, which met our inclusion criteria (<a href="#CD006278-sec-0051">Criteria for considering studies for this review</a>). This RCT recruited 26 children aged 4 to 12 years, and compared two interventions: the Nuffield Dyspraxia Programme‐3 (NDP‐3); and the Rapid Syllable Transitions Treatment (ReST). Treatments were delivered intensively in one‐hour sessions, four days a week for three weeks, in a university clinic in Australia. Speech pathology students delivered the treatments in the English language. </p> <p>We considered all core domains to be at low risk of bias. Both the NDP‐3 and ReST therapies demonstrated improvement at one month post‐treatment. A number of cases in each cohort had recommenced usual treatment by their speech and language pathologist between one month and four months post‐treatment (NDP‐3: 9/13 participants; ReST: 9/13 participants). Hence we could not analyse maintenance of treatment effects to four months post‐treatment without significant potential bias, and so we did not include this time point for further analysis in this review. </p> <p>Overall there is limited evidence that, when delivered intensively, both the NDP‐3 and ReST may effect improvement in word accuracy in 4‐ to 12‐year‐old children with CAS, measured by the accuracy of production on treated and non‐treated words, speech production consistency and the accuracy of connected speech. The study did not assess functional communication. We are unable to say whether either treatment is better than the other, or better than no treatment or treatment as usual. No evidence currently exists to support the effectiveness of other treatments for children aged 4 to 12 years with idiopathic CAS, without other comorbid neurodevelopmental disorders. No formal analyses were conducted to compare NDP‐3 and ReST by the original study authors, hence one treatment cannot be reliably advocated over the other. Further RCTs replicating this study would strengthen the evidence, which we currently rate as low using the GRADE evidence rating system (i.e. that 'further research is very likely to have an important impact on our confidence in the estimate and is likely to change the estimate'). </p> <p>Further well‐controlled studies investigating the effectiveness of other treatments for CAS are also needed across other motor‐based therapies, and also across linguistic and multi‐modal approaches. As noted earlier in the <a href="#CD006278-sec-0048">Why it is important to do this review</a> section, non‐RCT case series or case‐control studies examining motor, linguistic and multi‐modal interventions for CAS have described positive effects of intervention, but RCTs are required to strengthen the evidence base for these approaches. Further, there is also a need for trials that examine interventions for CAS compared to no treatment (e.g. wait‐list control group). A no‐treatment comparison is arguably difficult to achieve in this field however, given the typically severe presentation of speech disorder and reticence of parents or clinicians (or both) to withhold treatment from children. Finally, RCTs are also needed on populations with CAS and co‐occurring neurodevelopmental or medical disorders. </p> <p>Cochrane Reviews are often criticised in the SLP/SLT field because they do not allow consideration of lower levels of evidence, such as case studies or case series, which are more commonly performed in the field. Recognising these concerns we have provided a summary of the observational studies of CAS interventions excluded from this review (see <a href="#CD006278-tbl-0002">Table 1</a>), to encourage future, rigorous and controlled investigation of the efficacy of these methods. The lack of RCT intervention data in the CAS field to date is reinforced by challenges of: (1) the low incidence of the disorder; (2) the lack of a universally applied diagnostic classification system; (3) a lack of understanding of the aetiology of CAS; and (4) the challenge of designing trials for children with co‐occurring clinical features (e.g. non‐verbal cognitive impairment) or disorders (e.g. intellectual disability, autism spectrum disorder). </p> </section> <section id="CD006278-sec-0089"> <h3 class="title" id="CD006278-sec-0089">Overall completeness and applicability of evidence</h3> <p>We identified only one small RCT for inclusion in this review, indicating that there is an urgent need for further RCTs in this field. The interventions examined are currently in use and therefore results are applicable to clinical practice. </p> </section> <section id="CD006278-sec-0090"> <h3 class="title" id="CD006278-sec-0090">Quality of the evidence</h3> <p>We considered the overall quality of the evidence to be moderate using the GRADE approach; see <a href="./full#CD006278-tbl-0001">summary of findings Table for the main comparison</a>. We downgraded the quality of the evidence by one level to moderate, due to imprecision, given that only one RCT was identified. </p> </section> <section id="CD006278-sec-0091"> <h3 class="title" id="CD006278-sec-0091">Potential biases in the review process</h3> <p>We carefully managed potential conflicts of interest, as described below under <a href="#CD006278-sec-0139">Contributions of authors</a> and <a href="#CD006278-sec-0140">Declarations of interest</a>. There is a possible risk of language bias given that we only included studies written in English. </p> </section> <section id="CD006278-sec-0092"> <h3 class="title" id="CD006278-sec-0092">Agreements and disagreements with other studies or reviews</h3> <p>There are no other systematic reviews examining only RCT and quasi‐RCT evidence for efficacy of treatment for CAS. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006278-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/urn:x-wiley:14651858:media:CD006278:CD006278-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_t/tCD006278-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD006278-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p> Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006278-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/urn:x-wiley:14651858:media:CD006278:CD006278-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_t/tCD006278-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006278-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/media/CDSR/CD006278/image_n/nCD006278-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006278-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Nuffield Dyspraxia Programme ‐ Third Edition (NDP‐3) versus Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: children aged 4 to 12 years with CAS of unknown cause </p> <p><b>Settings</b>: University of Sydney Communication Disorders Treatment and Research Clinic </p> <p><b>Intervention</b>: NDP‐3 </p> <p><b>Comparison</b>: ReST </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Summary of MD findings</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Absolute MD</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b><i>Primary outcomes</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of production on treated items</b> </p> <p>Measured by: counting the number of real words produced correctly (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 36.0 was greater than the ReST MD of 33.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of production on non‐treated items</b> </p> <p>Measured by: counting the number of real words produced correctly (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ReST MD of 18.3 was minimally greater than the NDP‐3 MD of 18.2</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b><i>Secondary outcomes</i> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Speech production consistency</b> </p> <p>Measured by: calculating the number of inconsistent productions of 25 words produced 3 times using the DEAP inconsistency subtest<sup>b</sup> </p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 11.1 was greater than the ReST MD of 10.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Accuracy of connected speech</b> </p> <p>Measured by: counting the number of correct imitations of 3 word phrases (/x)</p> <p>Follow‐up: pre‐intervention to 1 month post‐intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NDP‐3 MD of 14.3 was greater than the ReST MD of 11.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 (1 trial)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate <sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence</p> <p><b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>CAS</b> : childhood apraxia of speech; <b>DEAP</b> : Diagnostic Evaluation of Articulation and Phonology; <b>MD</b> : mean difference; <b>NDP‐3</b> : Nuffield Dyspraxia Programme ‐ Third Edition;<b>ReST</b>: Rapid Syllable Transition Treatment (ReST) for Childhood Apraxia of Speech </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the quality of evidence by one level, to moderate, for imprecision, as there was only one study for comparison.<br/> <sup>b</sup>Note, a decrease in inconsistency is a positive outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006278-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded, low‐quality evidence from observational studies (case‐series, case control)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methodology/paper type</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention approach</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention intensity and duration</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Timing of outcome measures</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methodological considerations</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0002" title="BaasBS , StrandEA , LMElmer , BarbaresiWJ . Treatment of severe childhood apraxia of speech in a 12‐year‐old male with CHARGE association. Journal of Medical Speech‐language Pathology2008;16(4):181‐90. ">Baas 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 12.8 years with CAS and charge syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phase I and II: sessions 4 × per week; Phase III: weekly therapy. Study over 25 months. Home practice not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy on 2‐item scale for treated items; speech rate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phase I (core vocabulary): change on 4/6 targets. Maintained at last probe.</p> <p>Phase II (core vocabulary): reached 100% accuracy for 3/5 words. Reduction of stereotypies.</p> <p>Phase III: decreased speech rate from 94 to 71 SPM</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and during treatment. No longer‐term follow‐up data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines, control, longer‐term follow‐up or generalisation data. Clinical file data used. No replication across participants. Assessors, participants, therapists not blinded </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0003" title="BallardKJ , RobinDA , McCabeP , McDonaldJ . A treatment for dysprosody in childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2010;53(5):1227‐45. [DOI: 10.1044/1092‐4388(2010/09‐0130); PUBMED: 20798323] ">Ballard 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 siblings (2 males, 1 female) aged 7.8 and 10.10 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject multiple baseline design across behaviours and participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute sessions (100‐120 trials per session), 4 × per week for 12 sessions. Home practice not reported </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reading aloud 10 treated and 10 non‐treated non‐word strings; real word generalisation data; perceptual analysis of prosodic pattern and acoustic analysis using pairwise variability index </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/3 had significant gains in treated items and generalisation to same level of treated complexity. 2/3 generalised to lower and higher complexity non‐word items. Minimal generalisation to real words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline data taken at beginning of every 4th session and at 4 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No long‐term follow‐up data. Limited participants for generalisation of outcomes. No blinding of assessors, participants or therapists. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0004" title="BeathardB , KroutRE . A music therapy clinical case study of a girl with childhood apraxia of speech: finding Lily's voice. Arts in Psychotherapy2008;35(2):107‐16. [DOI: 10.1016/j.aip.2008.01.004] ">Beathard 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 3 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Music therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other (alternative interventions)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions over 9 months. 24 sessions in total</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Descriptive data only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Commenced non‐verbal. At end, had 11 phonemes in inventory</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment and post‐treatment. No follow‐up data</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No replicable outcome measures. No statistical analysis. No blinding of assessors, participants or therapists. No follow‐up or generalisation data. Unclear which aspect of treatment provided outcomes or affect of maturation, schooling, etc. No replication across participants. No long‐term follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0005" title="BingerC , LightJ . The effect of aided AAC modeling on the expression of multi‐symbol messages by preschoolers who use AAC. Augmentative and Alternative Communication2007;23(1):30‐43. [DOI: 10.1080/07434610600807470; PUBMED: 17364486] ">Binger 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 4.2 and 4.4 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of multi‐symbol messages in play scenarios</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of multi‐symbol messages using aided AAC as well as different types of messages. Maintained and generalised gains. Increased participation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. Limited outcome measures. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0006" title="BingerC , LightJ . The morphology and syntax of individuals who use AAC: research review and implications for effective practice. Augmentative and Alternative Communications2008;24(2):123‐38. [DOI: 10.1080/07434610701830587; PUBMED: 18465366] ">Binger 2008</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female (Latino) aged 3.4 years with CAS and suspected velocardiofacial syndrome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of multi‐symbol messages in play scenarios</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of multi‐symbol messages using aided AAC. Parental response to training excellent. Maintained and generalised gains </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and at 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0007" title="BingerC , Maguire‐MarshallM , Kent‐WalshJ . Using aided AAC models, recasts, and contrastive targets to teach grammatical morphemes to children who use AAC. Journal of Speech, Language, and Hearing Research2011;54(1):160‐76. [DOI: 10.1044/1092‐4388(2010/09‐0163); PUBMED: 20719874] ">Binger 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 6 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aided AAC Modeling</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15‐minute sessions, 1 to 3 × per week for 10 to 15 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of use of grammatical morphemes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more frequent use of grammatical morphemes using aided AAC. 2nd intervention period needed for 2/3 targets. Maintained gains </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every treatment session, and 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No blinding of assessors. No response generalisation data taken (only stimulus generalisation) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0008" title="BornmanJ , AlantE , MeiringE . The use of a digital voice output device to facilitate language development in a child with developmental apraxia of speech: a case study. Disability and Rehabilitation2001;23(14):623‐34. [PUBMED: 11697460] ">Bornman 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 6.6 years with CAS, hemiplegia and seizures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Voice output devices (Macaw)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute sessions for 2 sessions (training). Home practice focus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of appropriate responses to questions in structured discourse</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mother provided greater frequency and type of questions. Frequency of appropriate responses increased </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × baseline, 2 × practice period, 1 × post‐treatment, and 4 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data.<br/> CAS diagnosis unclear and not replicable. No statistical analysis.<br/> Limited outcome measures. No blinding of assessors. Unclear dosage of home practice. No generalisation data. No long‐term follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0010" title="CarterP , EdwardsS . EPG therapy for children with long‐standing speech disorders: predictions and outcomes. Clinical Linguistics and Phonetics2004;18(6‐8):359‐72. [PUBMED: 15573477] ">Carter 2004</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male and 1 female aged 12 and 8 years respectively diagnosed with CAS. Additional 8 children (7 males) aged 4 to 7 years with persistent articulation errors </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series ‐ single group study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Electropalatography (EPG) on /t, d, k, g, s, z/</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions, 1 × per week for 10 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent consonants correct (PCC) and Probe Scoring System (PSS) on probe of 43 words</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference noted for PSS for whole group. PCC scores improved in percentage</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment (baseline first session) and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up or generalisation data. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0012" title="CulpDM . Developmental apraxia and augmentative or alternative communication ‐ a case example. Augmentative and Alternative Communication1989;5(1):27‐34. [DOI: 10.1080/07434618912331274936] ">Culp 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 8 years with CAS and intellectual disability</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partners in Augmentative Communication Training (PACT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 to 90‐minute sessions daily after 3 days of intensive training. Home practice focus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ratio of parent vs participant messages; ratio of successful/intelligible messages from child </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant had greater frequency of messages compared to parent, and slightly higher frequency of successful measures (high baseline accuracy). Increased participation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment and 2 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0013" title="CumleyGD , SwansonS . Augmentative and alternative communication options for children with developmental apraxia of speech: three case studies. Augmentative and Alternative Communication1999;15(2):110‐25. [DOI: 10.1080/07434619912331278615] ">Cumley 1999</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 females and 1 male aged 3.4, 8 and 12.9 years respectively, with CAS (2 with intellectual disability and 1 with submucous cleft) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (3 case studies/reports)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined communication boards and voice output devices</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year‐old: 2 to 3 × per week for 12 weeks</p> <p>8‐year‐old: daily for 6 months</p> <p>12‐year‐old: not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year‐old: MLU.</p> <p>8‐year‐old: assessment of phonological processes; communication repairs.</p> <p>12‐year‐old: description of functional communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.4‐year old: minimal speech improvement, MLU increased to WNL</p> <p>8‐year old: no change in speech, parent report of greater communication repairs, and less frustration </p> <p>12‐year old: supplemented natural speech to initiate, maintain and repair communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐assessment and treatment descriptions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0014" title="DalePS , HaydenDA . Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. American Journal of Speech‐language Pathology2013;22(4):644‐61. [DOI: 10.1044/1058‐0360(2013/12‐0055); PUBMED: 23813194] ">Dale 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males and 1 female aged 3.6 to 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject (ABB or ABC) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT) ‐ full programme (FP) for 8 weeks versus PROMPT without tactile‐kinaesthetic‐proprioceptive cueing for 4 weeks and FP for 4 weeks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐minute session, 2 × per week for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained words on probe, untrained words. Pre‐post testing on the DEAP, TOCS+, VMPAC focal motor and sequencing subtests and Vineland socialization scales </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/4 improved on DEAP. 4/4 improved on TOCS+, VMPAC subtests and Vineland. All 4 showed greater improvement on easier targets and majority maintained to 3 months post‐treatment. Generalisation to untrained items noted </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe words: baseline × 3, treatment × 4, post‐treatment, and 3 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control as control data changed and interpreted as generalisation but no other control used (e.g. multiple baselines). CAS diagnosis concerning prosody unclear. Blinded assessors for only some outcomes. No withdrawal period between treatment phases and participant differences made comparison between conditions difficult. All measures not taken at consistent times </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0017" title="EdealDM , Gildersleeve‐NeumannCE . The importance of production frequency in therapy for childhood apraxia of speech. American Journal of Speech‐language Pathology2011;20(2):95‐110. [DOI: 10.1044/1058‐0360(2011/09‐0005); PUBMED: 21330650] ">Edeal 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 6.2 and 3.4 years with CAS (1 case with repaired cleft lip and palate and language disorder) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integral Stimulation (Dynamic Temporal and Tactile Cueing)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied across participants. 40‐minute sessions (15 minutes each condition plus probes). 1 case: 3 × per week for 11 weeks.<br/> 1 case: 2 × per week for 5 weeks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe data on targeted phonemes (articulation) in words for each participant. 1 phoneme targeted with high production frequency = 100 trials and another with moderate production frequency = 60 trials. Articulation and language sample taken at 2 weeks post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large effect sizes for high production frequency and moderate for moderate production frequency. Improvement in PCC and phoneme inventory post‐treatment. Some generalisation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, each treatment session, and 1 probe post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No long‐term follow‐up data. No blinding of assessors. Accuracy based on if target phoneme was correct (including cognate pair substitution) not if whole word was correct </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0021" title="HallPK . The occurrence of developmental apraxia of speech in a mild articulation disorder: a case study. Journal of Communication Disorders1989;22(4):265‐76. [PUBMED: 2794108] ">Hall 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 9 years with mild CAS (followed until 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study/report)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation therapy, motor‐programming remedial model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 school semesters</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Templin‐Darley Tests of Articulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Remediation of all 31 items for /r/, /ɝ/ and /ɚ/</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Test completed each semester</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up data or generalisation data. No replication across participants. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0023" title="HarrisL , DoyleES , HaafR . Language treatment approach for users of AAC: experimental single‐subject investigation. Augmentative and Alternative Communication (Baltimore, Md. : 1985)1996;12(4):230‐43. [DOI: 10.1080/07434619612331277698] ">Harris 1996</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 5 years with CAS and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Multiple baseline across discourse contexts)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Computer‐based AAC</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐minute sessions, 2 × per week for 22 sessions over 4 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Frequency of noun/verb phrases in reciprocal book reading and structured discourse</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in both contexts but more so in book reading than discourse. Some generalisation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline, treatment, and withdrawal probes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No follow‐up data. No blinding of assessors. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0026" title="Helfrich‐MillerKR . A clinical perspective: melodic intonation therapy for developmental apraxia. Clinics in Communication Disorders1994;4(3):175‐82. [PUBMED: 7994292] ">Helfrich‐Miller 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 2.9 to 8 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Melodic Intonation therapy (MIT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied. 37 to 71 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Varied. Description of skills, consonant inventories, sequencing error rates and intelligibility compared to typical development </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Child 1: all consonants in inventory</p> <p>Child 2: spoke in complex sentences, poor intelligibility, and articulation errors present. </p> <p>Child 3: sequencing error rate dropped from 75% to 22%. 13/18 consonant sounds improved</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No experimental control. Lack of information on diagnosis of CAS. Primarily descriptive measures ‒ not reliable or tested using statistics. No control, maintenance or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0027" title="IuzziniJ , ForrestK . Evaluation of a combined treatment approach for childhood apraxia of speech. Clinical Linguistics and Phonetics2010;24(4‐5):335‐45. [DOI: 10.3109/02699200903581083; PUBMED: 20345262] ">Iuzzini 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 3.7 to 6.10 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stimulability (STP) and modified Core Vocabulary (mCVT) used concurrently</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55‐minute sessions (10 minutes STP, 45 minutes mCVT), 2 × per week for 20 sessions. No home practice </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent phonemes correct, phonetic inventory and inconsistency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PCC increased on average 20% after combined therapy (range 9% to 32%). Inventory gained 5 phones on average (range 1 to 10). 3/4 had greater consistency on CSIP and ISP after therapy; 1 had greater inconsistency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor experimental control as stable baseline not established, lack of control data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No immediate post‐treatment data or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0028" title="JaromaM , DannerP , KoivuniemiE . Sensory integrative therapy and speech therapy for improving the perceptual motor skills and speech articulation of a dyspractic boy. Folia Phoniatrica1984;36(6):261‐6. [DOI: 10.1159/000265753] ">Jaroma 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 5.5 years with "some dyspraxic features" (CAS diagnosis not explicit)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sensory integrative therapy and speech therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily sessions for 2 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(SP only) Illinois Test of Psycholinguistic Abilities</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Test not completed post‐treatment. Observation of greater self‐monitoring and correction of speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment only</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures and no post‐treatment data.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants.<br/> Lack of information on speech therapy provided </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0029" title="KadisDS , GoshulakD , NamasivayamA , PukonenM , KrollR , DeNilLF , et al. Cortical thickness in children receiving intensive therapy for idiopathic apraxia of speech. Brain Topography2014;27(2):240‐7. [DOI: 10.1007/s10548‐013‐0308‐8; PMC3921462; PUBMED: 23974724] ">Kadis 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 children (9 males, 5 females) aged 3 to 6 years with diagnosed CAS (compared to 14 age‐matched controls) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series pre‐post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × per week for 8 weeks (16 sessions in total)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2, HCAPP,</p> <p>VMPAC, MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains as a group for all speech measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐week pre‐treatment (baseline), 1‐week post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CAS diagnosis unclear and not replicable. Age‐matched control group older than CAS group. Limited information on PROMPT targets selected for replication. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0031" title="KingAM , HengstJA , DeThorneLS . Severe speech sound disorders: an integrated multimodal intervention. Language, Speech, and Hearing Services in Schools2013;44(2):195‐210. [DOI: 10.1044/0161‐1461(2012/12‐0023); PUBMED: 23633644] ">King 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males aged 4.1, 5.8 and 8.6 years diagnosed with CAS. 1 of the 3 diagnosed with Opitz FG syndrome and another with PDD‐NOS </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject multiple baseline across participants design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Multimodal Intervention (structured book reading, drill and play activities with AAC devices present and speech encouraged) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐hour sessions, 2 × per week for 3 to 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Category (e.g. vocalisation, AAC or both), type of word and accuracy targets.</p> <p>Case 1: final consonants.</p> <p>Case 2: initial /s/ clusters then /f/.</p> <p>Case 3: initial /s/ clusters</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increases in vocalisations/spoken speech noted for 3/3. Speech accuracy improved on targets for 1/3 cases but all showed some generalisation to more accurate everyday speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline probes, probes every 2nd treatment session, 1‐month post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Poor experimental control for case 1 and some change on control data noted. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No generalisation data. No long‐term treatment data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0033" title="KlickSL . Adapted cuing technique for use in treatment of dyspraxia. Language, Speech, and Hearing Services in Schools1985;16:256‐9. [DOI: 10.1044/0161‐1461.1604.256] ">Klick 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5.6 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case description)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adapted Cueing Technique</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 minutes of therapy per day for 6 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of single words/utterances</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>From 2 to 4 words to 12 words and several carrier phrases. After 6 months began to produce novel sentences </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Description of progress during treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0034" title="KraussT , GallowayH . Melodic intonation therapy with language delayed apraxic children. Journal of Music Therapy1982;19(2):102‐13. [DOI: 10.1093/jmt/19.2.102] ">Krauss 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 5 and 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABAA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concurrent Melodic Intonation Therapy (MIT) and traditional therapy (20% and 80% of sessions respectively) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × per week over 2‐month period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment gains on word‐morpheme usage, auditory comprehension, naming, describing function, sentence completion, imitation of word phrases and articulation. Tested using language sampling and Porch Index of Communicative Ability in Children </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains were found in phrase length (MLU), picture naming, and verbal imitation tasks. Little change in articulation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment, post‐traditional therapy, and post‐MIT therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No long‐term follow‐up. There were no reliability data reported for language sample analysis, a subjective measure </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0035" title="LagasseB . Evaluation of melodic intonation therapy for developmental apraxia of speech. Music Therapy Perspectives2012;30(1):49‐55. [DOI: 10.1093/mtp/30.1.49] ">Lagasse 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 males aged 5 and 6 years with suspected CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Melodic Intonation Therapy (MIT) compared to 'traditional speech‐language therapy'</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing 1 × per week speech therapy (traditional articulation sessions) and 40‐minute MIT music sessions over 4 weeks (both treatments concurrent) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2; KLPA2 and speech production on stimulable sounds in 1‐ or 2‐syllable words</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case 1 made greater gains in MIT sessions (but only 2% gain). Case 2 made greater gains on traditional articulation therapy (15% gain) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0037" title="LükeC . Impact of speech‐generating devices on the language development of a child with childhood apraxia of speech: a case study. Disability and Rehabilitation. Assistive Technology2016;11(1):80‐8. [DOI: 10.3109/17483107.2014.913715; PUBMED: 24773213] ">Lüke 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 German‐speaking male aged 2.7 years with severe CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single case design (A‐B design with 3 follow‐up assessments post‐treatment with some treatment sessions between assessments) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speech Generating Devices ‒ fixed display (Gotalk 20+) and dynamic display (DynaVox V) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute sessions × 50 treatment sessions. Treatment sessions 2 to 28 days apart</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Means of communication (oral versus SGD), intelligibility of speech productions, consistency of speech productions, lexical development, and grammatical development </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significantly more communication initially with SGD than speech; significant increase in speech intelligibility; consistency (however reduced data in baseline period); amount of words used; and increased MLU and inflections after 8 to 9 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3, every 2nd treatment session, and 2, 4 and 8 weeks post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of baseline data for consistency. CAS diagnosis unclear and not replicable. No blinding of assessors. No clear withdrawal phase after treatment with SGDs for control and no generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0038" title="LundeborgI , McAllisterA . Treatment with a combination of intra‐oral sensory stimulation and electropalatography in a child with severe developmental dyspraxia. Logopedics, Phoniatrics, Vocology2007;32(2):71‐9. [DOI: 10.1080/14015430600852035; PUBMED: 17613788] ">Lundeborg 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5.1 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case cross‐over design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intra‐oral stimulation and electropalatography</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25‐minute sessions (5 minutes intra‐oral stim, 20 minutes EPG); daily at home, total of 195 sessions in 12 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent consonants correct, per cent phonemes correct, per cent words correct, intelligibility, visual deviancy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant treatment outcomes on all measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐testing, A1 (baseline), B (intervention: oral stimulation therapy), A2 (withdrawal for 3 months), B (intervention: EPG), and A3 (follow‐up) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cross‐over design, no control group or data taken to control for maturation. No replication across participants. No long‐term follow‐up or generalisation data taken </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0039" title="MaasE , ButallaCE , FarinellaKA . Feedback frequency in treatment for childhood apraxia of speech. American Journal of Speech‐language Pathology2012;21(3):239‐57. [DOI: 10.1044/1058‐0360(2012/11‐0119); PUBMED: 22442284] ">Maas 2012a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 5.4 to 8.4 years with CAS (2 also with dysarthria and a third with language disorder); 3 also in <a href="./references#CD006278-bbs2-0040" title="MaasE , FarinellaKA . Random versus blocked practice in treatment for childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2012;55(2):561‐78. [DOI: 10.1044/1092‐4388(2011/11‐0120); PUBMED: 22207698] ">Maas 2012b</a>, as below </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over<br/> 2 phases) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing (high versus moderate feedback frequency in cross‐over design) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50‐minute sessions 3 × per week for 3 participants but 1 had 60‐minute sessions 2 × per week </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of target words and phrases with 2 words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 responded better to low frequency feedback, 1 to high frequency feedback, and 1 to no condition. No generalisation effects </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Different doses across all participants. Treatment fidelity &lt; 80%. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0040" title="MaasE , FarinellaKA . Random versus blocked practice in treatment for childhood apraxia of speech. Journal of Speech, Language, and Hearing Research2012;55(2):561‐78. [DOI: 10.1044/1092‐4388(2011/11‐0120); PUBMED: 22207698] ">Maas 2012b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males and 2 females) aged 5.0 to 7.9 years with CAS. 2 cases had additional dysarthria diagnoses. </p> <p>1 other case had multiple co‐occurring disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case alternating treatments design with multiple baselines across behaviours over<br/> 2 phases) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing (random versus blocked practice compared in cross‐over design) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 4 week blocks of therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on 2‐point scale of segmental and suprasegmental aspects of entire target words and phrases with 2 words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/4 responded to both conditions. 2 responded relatively better to blocked practice, 1 to random practice, and 1 to no condition. 2/4 demonstrated generalization </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly probes: 3 to 4 × baseline, 4 × treatment. Phase 1: 4 to 5 × withdrawal, 4 × treatment. Phase 2: 2 × withdrawal and 1 month post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size with heterogeneity. Cross‐over conditions made comparison difficult regarding targets chosen. No control group. Effect sizes used not interpretable or comparable to others. Treatment fidelity &lt; 80%. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0041" title="MartikainenA‐L , KorpilahtiP . Intervention for childhood apraxia of speech: a single‐case study. Child Language Teaching and Therapy2011;27(1):9‐20. [DOI: 10.1177/0265659010369985] ">Martikainen 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 4.7 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Multiple baseline across behaviours ‐ cross‐over treatment design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined Melodic Intonation Therapy (MIT) and Touch Cue Method (TCM)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor and linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 sessions for 6 weeks for 18 sessions for MIT. 6 weeks no therapy. 3 sessions for 6 weeks for 18 sessions for TCM </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy: PVC, PCC. Also, overall word accuracy scores: PMLU, PWP, PWC.</p> <p>All calculated from responses to 46 picture cards</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/5 measures significant post‐MIT (per cent vowels correct). Per cent consonants correct also reduced. </p> <p>3/5 significant post‐TCM (PVC, PCC, PMLU).</p> <p>PVC, PCC and PMLU maintained.</p> <p>Greater changes for both therapies after withdrawal. PCC and PMLU only significant after MIT withdrawn </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beginning and end of 6‐week baseline, beginning and end of both treatment phases, 12 weeks after TCM withdrawn </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control of other factors. Cross‐over design makes comparison of both treatments difficult as many changes only noted after withdrawal of MIT (accumulation effects). Limited outcome data. Lack of generalisation data No blinded assessors. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0042" title="MartinMK , WrightLE , PerryS , CornettD , SchraederM , JohnsonJT . Children with developmental verbal dyspraxia: changes in articulation and perceived resilience with intensive multimodal intervention. Child Language Teaching and Therapy2016;32(3):261‐75. [DOI: 10.1177/0265659015615924] ">Martin 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (sex unknown) aged 3 to 10 years with CAS (11 with co‐occurring conditions)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case series (pre and post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DuBard Association Method®. It is a multimodal, phonetic therapy which works from accurate sounds in isolation </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily in small groups in a school programme for an 11‐month period</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, mean length of utterance (MLU), and intelligibility on Arizona Articulation Proficiency<br/> Scale‐Third Revision (AAPS‐3) and perceptions of resilience judged by parents and SLPs </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant changes in articulation, intelligibility and MLU, and some resilience measures over 2‐year period </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control regarding maturation effects (despite using the Intervention Efficiency Index and Proportional Change Index) and lack of control of covariate, including other potential intervention over the same period. No control group. No follow‐up or generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0043" title="McCabeP , Macdonald‐D'SilvaAG , vanReesLJ , BallardKJ , ArciuliJ . Orthographically sensitive treatment for dysprosody in children with childhood apraxia of speech using ReST intervention. Developmental Neurorehabilitation2014;17(2):137‐46. [DOI: 10.3109/17518423.2014.906002; PUBMED: 24694312] ">McCabe 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 males aged 5.5 to 8.6 years with CAS. 2 children had additional auditory processing impairments </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (AB) design with 1 month follow‐up)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute session, 4 × per week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, prosodic and simultaneous articulation and prosodic accuracy on trained and untrained probe pseudo words; PCC, PVC and per cent lexical stress matches from connected speech; PPVT‐4 as control data </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All 4 participants increased perceptual accuracy. 1/4 participants showed change in untreated items. All participants showed change in prosody (average prosody gain 58%, 3/4 in PVC and 2/4 in PCC; average gain 79%). Control data (receptive vocabulary on PPVT‐IV) changed minimally </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 2, probes in treatment × 2, 1 month follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was no immediate post‐treatment data taken to determine treatment effects, the follow‐up data was 1 month post‐treatment and included a withdrawal phase. There was no statistical analysis of connected speech data. 1 participant reached ceiling. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 4.2 to 7.6 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness Intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trained speech accuracy and phonological awareness accuracy on a probe. Generalisation‐ BTOPP and first trial of DEAP inconsistency subtest for PVC, PVC and inconsistency score. PIPA for 4‐year‐olds. TOPA for 5 to 7‐year‐olds. Burt Word Reading Test for non‐word reading and informal non‐word reading probe (<a href="./references#CD006278-bbs2-0082" title="GillonGT . The efficacy of phonological awareness intervention for children with spoken language impairment. Language, Speech and Hearing Services in Schools2000;31(2):126‐41. [DOI: 10.1044/0161‐1461.3102.126; PUBMED: 27764385] ">Gillon 2000</a>). Per cent grapheme correct score in spelling 10 words from DEAP inconsistency subtest </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Speech: 9/12 children improved on trained items. Phonological awareness: 8/12 children improved in 1 or both intervention blocks. Generalisation for 8/12 on all measures except Burt Word Reading Test </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0045" title="McNeillBC , GillonGT , DoddB . A longitudinal case study of the effects of an integrated phonological awareness program for identical twin boys with childhood apraxia of speech (CAS). International Journal of Speech‐language Pathology2009;11(6):482‐95. [DOI: 10.3109/17549500902842583; PUBMED: 21271925 ] ">McNeill 2009b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 male identical twins aged 4.5 years with CAS (deletion at 10q21.2‐22.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session; 2 × per week for 6 weeks in 2 blocks with 6‐week withdrawal between blocks. Total of 245 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPC, PVC on BTOPP, and DEAP inconsistency percentage. PIPA, PhonRep, Burt Word Reading, Non‐word Reading, Neale accuracy and comprehension </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PCC and PVC improved at post‐treatment and follow‐up. Reduced inconsistency. Sound‐letter knowledge increased from 0 to 7 at post‐treatment. Reading WNL and spelling demonstrated use of strategies at final follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment, and 6‐month follow‐up</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group or control data. CAS diagnosis unclear regarding prosody. Limited information provided on each participant. Limited treatment phase data. No maintenance data. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0046" title="McNeillBC , GillonGT , DoddB . The longer term effects of an integrated phonological awareness intervention for children with childhood apraxia of speech. Asia Pacific Journal of Speech, Language, and Hearing2010;13(3):145‐61. [DOI: 10.1179/136132810805335074] ">McNeill 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 4.2 to 7.6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (12‐month follow‐up to 2009 case series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>As per <a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BBTOP and 1st trial of DEAP yielding PPC. PIPA for 4‐year‐olds &amp; TOPA for 5 to 7‐year‐olds. Decoding measures (Burt Word Reading Test and Non‐word Reading Task) and spelling measures (probe of 10 words from the DEAP inconsistency subtest) were completed for participants at least 6 years of age at the beginning of the study. The NARA was administered for participants aged 5 years, 6 months and up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference for CAS group from pre‐ to post‐treatment on letter knowledge, non‐word reading probe, spelling, PCC, TOPA and Burt Non‐Word Reading. 3/7 improved on NARA to age‐appropriate level </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1‐year follow‐up to <a href="./references#CD006278-bbs2-0044" title="McNeillBC , GillonGT , DoddB . Phonological awareness and early reading development in childhood apraxia of speech (CAS). International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2009;44(2):175‐92. [DOI: 10.1080/13682820801997353; PUBMED: 19234970] ">McNeill 2009a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/12 of original participants followed up. Whole group data ‒ case series. No control group or control data for experimental control or maturation effects </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0048" title="MoriartyBC , GillonGT . Phonological awareness intervention for children with childhood apraxia of speech. International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2006;41(6):713‐34. [DOI: 10.1080/13682820600623960; PUBMED: 17079224] ">Moriarty 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 6.3, 6.10 and 7.3 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design across behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integrated Phonological Awareness Intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute sessions 3 × per week for 3 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PPC on probe, phoneme segmentation probe, phoneme manipulation probes, initial sound identification probes, letter‒sound knowledge subtest from the PIPA, non‐word reading tasks </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/3 significantly increased PPC, 2/3 significantly improved phonological awareness skills on probes, letter‒sound knowledge, and non‐word reading. Limited transfer to untreated words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline and post‐treatment (3 probes each)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of control group and control data. CAS diagnosis unclear regarding prosody. Lack of multiple baseline data throughout treatment. No long‐term follow‐up. No blinding of assessors </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0049" title="NamasivayamAK , PukonenM , GoshulakD , YuVY , KadisDS , KrollR , et al. Relationship between speech motor control and speech intelligibility in children with speech sound disorders. Journal of Communication Disorders2013;46(3):264‐80. [DOI: 10.1016/j.jcomdis.2013.02.003; PUBMED: 23628222] ">Namasivayam 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 children (9 males, 3 females) aged 3 to 6 years with speech sound disorders</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series pre‐post design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prompts for Restructuring Oral Muscular Phonetic Targets (PROMPT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session 2 × per week for 8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA2, HCAPP, VMPAC focal motor and sequencing subtests, Children's Speech Intelligibility Measure </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant gains as a group for all speech measures</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline 1 week prior to treatment, and 1 week post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, control group, multiple baseline or control data. No blinding of assessors. No blinding of assessors. No long‐term follow‐up </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0050" title="NamasivayamA , PukonenM , HardJ , JahnkeR , KearneyE , KrollR , et al. Motor speech treatment protocol for developmental motor speech disorders. Developmental Neurorehabilitation2015;18(5):296‐303. [DOI: 10.3109/17518423.2013.832431; PUBMED: 24088085] ">Namasivayam 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 children (28 males, 9 females) aged 2.6 to 4.5 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (pre‐postgroup design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor Speech Treatment Protocol (MSTP)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intense treatment group: 45‐minute session, 2 × per week × 10 weeks = 20 sessions. Less intense group: 45‐minute session, 1 × per week × 10 weeks = 10 sessions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GFTA‐2 sounds in words subtest; speech intelligibility using Children's Speech Intelligibility Measure (CSIM) at word level, and Beginner's Intelligibility Test (BIT) at sentence level. Functional Outcomes for Children Under Six (FOCUS) scale </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intense group had greater changes in articulation and functional communication compared to the less intense group with large effect sizes. Mixed results were found for intelligibility: at word‐level (CSIM), both the less intense and 1/2 intense groups made a significant and large change. At sentence level, 1/2 intense groups made a significant change </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group or control data. Participants were not directly randomised; however, no between‐group differences were found at baseline. There were missing data (dealt with using intention‐to‐treat analysis). No information on session trials was obtained, which is important for intensity calculations </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0051" title="PrestonJL , BrickN , LandiN . Ultrasound biofeedback treatment for persisting childhood apraxia of speech. American Journal of Speech‐language Pathology2013;22(4):627‐43. [DOI: 10.1044/1058‐0360(2013/12‐0139); PUBMED: 23813207] ">Preston 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 males aged 9 to 15 years with CAS. 1 child had additional ADHD and another child had additional dysarthria </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (targeting articulation on clusters and CV or VC sequences of inaccurate phones) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 minute sessions, 2 × per week × 18 sessions (at least 150 trials per session)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe of whole‐word accuracy of treated and untreated items</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>U002 and U007 had significant gains on 2/4 treated combinations, U005 for 3/4, and U008, U009 and U012 had significant gains on all treated combinations. All exhibited some generalisation (target‐dependant). U005, U007, U008, U009, U012 demonstrated maintenance above pre‐treatment levels </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probes at baseline × 3, every treatment session, post‐treatment, and 2 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group or comparison treatment. No blinding of assessors. Untreated items were not clearly selected as control or generalisation data with some showing change and others not </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0052" title="PrestonJL , LeeceMC , MaasE . Intensive treatment with ultrasound visual feedback for speech sound errors in childhood apraxia. Frontiers in Human Neuroscience2016;10:440. [DOI: 10.3389/fnhum.2016.00440; PMC5003919; PUBMED: 27625603] ">Preston 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 male children aged 11 to 13 years diagnosed with CAS and poor expressive language and phonological processing. 1 participant had additional flaccid dysarthria, ADHD, language and learning difficulties </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across behaviours (syllable positions))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (using structured chaining and principles of motor learning)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 hour sessions × 14 sessions. Sessions 1 to 7 addressed target 1 and sessions 8 to 14 addressed target 2 with randomly assigned prosody or no prosody conditions </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment acquisition data, generalisation probe of untreated words, maintenance to 2 months post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/3 participants acquired accurate articulation. 0/3 demonstrated generalisation or maintenance </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 × baseline probes, midway therapy probe, post‐therapy probe (within 1 week after treatment), and 2‐month follow‐up </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No control group. Greater within‐treatment probes and post‐treatment probes would have allowed for greater statistical analysis. No control data. No blinding of assessors. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0053" title="PrestonJL , LeeceMC , MaasE . Motor‐based treatment with and without ultrasound feedback for residual speech‐sound errors. International Journal of Language and Communication Disorders2017;52(1):80‐94. [DOI: 10.1111/1460‐6984.12259; PMC5156595; PUBMED: 27296780] ">Preston 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 males aged 11 to 14 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi/RCT</p> <p>(Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound biofeedback (using structured chaining and principles of motor learning.)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (Instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 1‐hour articulation treatment a day for 2 weeks. 16 hours of therapy in total. Over 100 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment acquisition of /ɹ/, /s/ or /ʧ/. Generalisation to untrained items using a probe and sentence imitation task, and maintenance 1 to 3 weeks post‐treatment (audio‐samples submitted) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case 1 had acquisition, generalisation, and maintenance of targets. Case 2 had some acquisition in the 2nd week of therapy and no generalisation and maintenance. Case 3 showed acquisition, limited generalisation to words and not phrases, and no maintenance </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probe conducted 1 × before treatment, at the end of the first week, and at the end of the second week (post‐treatment) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No blinding of assessors. No long‐term follow‐up data. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0054" title="RayJ . Effects of orofacial myofunctional therapy on speech intelligibility in individuals with persistent articulatory impairments. International Journal of Orofacial Myology2003;29:5‐14. [PUBMED: 14689652] ">Ray 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 adult with CAS and class III malocclusion. Another 5 adults aged 18 to 23 years with persistent articulation disorders </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case series)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Orofacial myofunctional therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (Instrumentally based)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐minute session, 1 × per week for 6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dworkin‐Culatta Oral Mechanism Examination for oral postures and intelligibility in single words, sentences, and spontaneous speech </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All improved lips and tongue postures. 5/6 participants increased intelligibility. No improvement in intelligibility for person with DVD </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. No treatment data or follow‐up reported. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No immediate post‐treatment data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0056" title="RosenbekJ , HansenR , BaughmanCH , LemmeM . Treatment of developmental apraxia of speech: a case study. Language, Speech, and Hearing Services in Schools1974;5:13‐22. [DOI: 10.1044/0161‐1461.0501.13] ">Rosenbek 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 9 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intensive, systematic drill motor therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 sessions over 3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐item probe of /r/ (target), ineligibility in spontaneous speech</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/r/ improved from 0 to 20 correct in probe. Intelligibility judged by unfamilar listeners improved </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No follow‐up data. Only ancedotal generalisation data. No statistical analysis. No reliability of judgments reported. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0057" title="RosenthalJB . Rate control therapy for developmental apraxia of speech. Clinics in Communication Disorders1994;4(3):190‐200. [PUBMED: 7994294] ">Rosenthal 1994</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (3 males, 1 female) aged 10‐14 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single subject (ABAB) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate Control Therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic and motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20‐minute session per reading passage. No further information available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy (words read correctly)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improved to 85% accuracy at 50% habitual rate and maintained in therapy as rate was slowly increased. Limited generalisation to conversation ‐ therapy implemented </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reading rate in 5‐minute intervals</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of control and follow‐up data. CAS diagnosis unclear and not replicable. No statistical analysis. No blinding of assessors. No stimulus generalisation measures. No report of data reliability </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0058" title="SkeltonSL , HagopianAL . Using randomized variable practice in the treatment of childhood apraxia of speech. American Journal of Speech‐language Pathology2014;23(4):599‐611. [DOI: 10.1044/2014_AJSLP‐12‐0169; MEDLINE: 25017177] ">Skelton 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children (2 males, 1 female) aged 4 to 6 years diagnosed with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Concurrent treatment (using randomised variable practice)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Therapy until target sounds reached 80% accuracy. P1 had 26, P2 had 12 and P3 had 28 sessions. 2 × per week, 30 minutes per session and on average 100 to 115 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent correct productions on /s, z, f, v/ trained targets during baseline and treatment; generalisation probes to untrained words and 3‐word phrases </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children reached 80% accuracy on target sounds. Moderate to large generalisation effects at word and 3‐word phrases levels (70% to 100% accuracy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 × baseline probes, probes every 5 therapy sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No post‐treatment or follow‐up/maintenance data. No blinded assessors. No stimulus generalisation data. P3 continued regular school therapy during the study so could be a confounding factor. No stimulus generalisation measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0060" title="StokesSF , GriffithsR . The use of facilitative vowel contexts in the treatment of post‐alveolar fronting: a case study. International Journal of Language &amp; Communication Disorders / Royal College of Speech &amp; Language Therapists2010;45(3):368‐80. [DOI: 10.3109/13682820903094737; PUBMED: 20144008] ">Stokes 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 7 years with residual CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case (ABA) design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation with facilitative vowel contexts</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45‐ to 55‐minute session, 3 × per week for 3 weeks. 60+ trials per session. Home practice provided </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on 'sh' sound in word initial probe, 'tr' as control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement in 'sh' articulation accuracy in trained and untrained words. No change in control words with 'tr' initial </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐treatment, mid‐therapy × 2 (after sessions 3 and 6), post‐treatment, and maintenance (2 weeks post‐treatment) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participant did not meet current CAS criteria. Lack of generalisation data beyond 'sh' sound. No blinded assessors. No replication across participants. No long‐term follow‐up data. No reliability of data reported </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0061" title="StrandEA , DebertineP . The efficacy of integral stimulation intervention with developmental apraxia of speech. Journal of Medical Speech‐language Pathology2000;8(4):295‐300. [www.researchgate.net/publication/286964810_The_efficacy_of_integral_stimulation_intervention_with_developmental_apraxia_of_speech] ">Strand 2000</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 5 years with "severe motor planning deficits but no dysarthria" (CAS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Integral stimulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐ to 50‐minute session, 3 to 5 × per week (1 to 2 × per day) for 10 to 16 sessions. No home practice </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy ratings on a 2‐point scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement from 0.25 to 0.80 on 2‐point scale. 4/5 treatment stimuli achieved rating of 2/2 by end of therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treated stimuli at start of each session, control stimuli twice a week</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up data or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0062" title="StrandEA , StoeckelR , BaasB . Treatment of severe childhood apraxia of speech: a treatment efficacy study. Journal of Medical Speech‐language Pathology2006;14(4):297‐307. [psycnet.apa.org/record/2006‐22884‐013] ">Strand 2006</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 males aged 5.5 to 6.1 years with CAS (2 with dysarthria and 1 with mild intellectual disability) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dynamic Temporal and Tactile Cueing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30‐minute sessions, 2 × per day for 5 days a week for 38 to 50 sessions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation accuracy on a 3‐point scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment gains for 3/4 participants maintained by 2/4</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 4 (or more, staggered baseline), 20+ treatment probes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No follow‐up or generalisation data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0063" title="ThomasDC , McCabeP , BallardKJ . Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech: the effect of lower dose‐frequency. Journal of Communication Disorders2014;51:29‐42. [DOI: 10.1016/j.jcomdis.2014.06.004; PUBMED: 25052390] ">Thomas 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 children (2 males, 2 females) aged 4.8 to 8 years with CAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case multiple baseline across participants and behaviours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 minute sessions 2 × per week for 6 weeks. 100 trials per session</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on imitated (a) treated words, (b) untreated pseudo words, (c) untreated real words and control words </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement on treated words and untreated real words. Significant improvement for 2/4 participants on untreated pseudo words. No change in control items </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline × 3 to 6, treatment × 3, and 1 day, 1 month and 4 months post‐treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use of GFTA2 for control items. No stimulus generalisation data</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0064" title="ThomasDC , McCabeP , BallardKJ , LincolnM . Telehealth delivery of Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech. International Journal of Language &amp; Communication Disorders2016;51(6):654‐71. [DOI: 10.1111/1460‐6984.12238; PUBMED: 27161038] ">Thomas 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 children (4 males, 1 female) aged 5 to 11 years with CAS (3 with mild or moderate receptive language disorder) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT<br/> (Single case multiple baseline across participants) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rapid Syllable Transition Treatment (ReST)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor (instrumentally based ‐ telehealth)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60‐minute session, 4 times a week for 3 weeks (12 sessions in total). Minimum of 1200 trials per session </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Accuracy on treated pseud‐word items, generalisation to untreated non‐words and real words, and control items (articulation of rhotics) on a probe; client/family satisfaction with telehealth treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/5 participants demonstrated significant change in treated items. 4/5 maintained gains to 4 months post‐treatment. 4/5 had significant generalisation to untrained non‐words and real words, and 1/5 demonstrated change in control data (articulation errors of rhotics or /s/). Families very satisfied and motivated by telehealth treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 3 baseline probes, 3 therapy probes (sessions 5, 9 and 1 day post‐treatment). Follow‐up at 1 week, 4 weeks &amp; 4 months post‐treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Missing data for some participants at certain time points in Table 3. Problems with change in control data. Some internet issues (dropouts, port sound quality, etc.) were observed in 61% of sessions; however, significant outcomes were found. No stimulus generalisation data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0065" title="TierneyCD , PitterleK , KurtzM , NakhlaM , TodorowC . Bridging the gap between speech and language: using multimodal treatment in a child with apraxia. Pediatrics2016;138(3):e20160007. [DOI: 10.1542/peds.2016‐0007; PUBMED: 27492818] ">Tierney 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 3 years with CAS and fine motor delay</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT</p> <p>(Single case design; descriptive)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multimodal therapy: Signed Exact English sign language, Sarah Rosenfeld Johnson's oro‐motor programme and Kaufman Speech Praxis Program </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Augmentative and alternative communication</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinic‐based sessions 45 minutes 1 to 2 × per week and home‐based sessions for 60 minutes 1 × per week </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Language assessment; observations and Kaufman Speech Praxis Test; Verbal Motor<br/> Production Assessment for Children (VMPAC) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Receptive and expressive language consistently in average range but receptive relatively better than expressive language. By 3.6 years of age receptive and expressive language same level. Marked drooling and limited inventory and sequencing at 18 months, yet skills on Kaufman &amp; VMPAC in average range at 3 years, 9 months. Discharged from therapy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Language assessment at 1.1 year, 3 years and 3.6 years. Kaufman test or observations at 1.6, 3 and 3.9 years. VMPAC at 3 years, 9 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable regarding prosody and drooling. No statistical analysis.<br/> No blinding of assessors. No replication across participants. Limited repeated measures on same instrument. Participant had multiple therapies concurrently </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0066" title="VashdiE . Using VML (verbal motor learning) method techniques in treatment of prosody disorder due to childhood apraxia of speech: a case study. International Journal of Child Health and Human Development2013;6(2):255‐60. [www.novapublishers.com/catalog/product_info.php?products_id=52658] ">Vashdi 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 male aged 14 years with severe CAS and limb/motor apraxia and obsessive compulsive disorder </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Verbal Motor Learning (with Dynamic Distal Stabilization Technique (DDST))</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 × 30‐minute clinic session and 6 × home practice sessions a week for 4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(1) Producing highest pitch using /I/ sound with and without DDST, to determine minimum and maximum frequency and length using Speech Analyser 1.5 </p> <p>(2) Imitation of 18 words to analyse word length, maximum loudness, maximum and minimum frequency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant t‐test results for (1) increase in maximum frequency and length of pitch after DDST, no change in minimum frequency, and (2) decrease in word length (word said faster), maximum loudness, and maximum frequency </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Unclear data analysis procedures (unclear if they used visual analysis or perceptual analysis, and if they tested assumptions for the statistical analysis completed) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0067" title="VashdiE . The influence of initial phoneme cue technique on word formation: a case study of a child with apraxia of speech and autism. International Journal of Child Health and Human Development2014;7(2):197‐203. [www.novapublishers.com/catalog/product_info.php?products_id=53974] ">Vashdi 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 10 years with CAS and ASD</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Verbal Motor Learning (Initial Phoneme Cue (IPC) technique)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 1 hour sessions, 2 weeks apart (participant had initial therapy: 1‐hour session weekly for 1 year prior to this study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imitation accuracy of CVCV treated words either (a) with IPC or (b) without IPC</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Imitation of CVCV was 0% to 22% accuracy and imitation with IPC was 96% to 100% accuracy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures. No statistical analysis. No blinding of assessors. No follow‐up or generalisation data. No replication across participants </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0069" title="YossKA , DarleyFL . Developmental apraxia of speech in children with defective articulation. Journal of Speech and Hearing Research1974;17(3):399‐416. [PUBMED: 4421901] ">Yoss 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 children (no information on gender reported) aged 6 to 11 years with moderate to severe DAS </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Case descriptions/file audit)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>School‐based intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Motor</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 to 307 hours of therapy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Articulation, polysyllable words and connected speech in speech samples. Intelligibility rated on a 9‐point scale </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant improvement on articulation. Minimal generalisation to polysyllable words and connected speech. Intelligibility improved by at least 0.5 points </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pre‐ and post‐ treatment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis.<br/> No blinding of assessors. No follow‐up data </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD006278-bbs2-0070" title="ZaretskyE , VellemanSL , CurroK . Through the magnifying glass: underlying literacy deficits and remediation potential in childhood apraxia of speech. International Journal of Speech‐language Pathology2010;12(1):58‐68. [PUBMED: 20380250] ">Zaretsky 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 female aged 11.6 years with CAS, intellectual disability and language disorder</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not quasi‐/RCT (Single case design)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phonological awareness (phoneme‒grapheme mapping, reading comprehension, 'Basics' programme). Speech ‐ PROMPT and Moving Across Syllables </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Linguistic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Between 6.0 and 11.6 ongoing weekly treatments ‐ 1 hour × 1:1 sessions and PROMPT institute over summer </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Per cent accuracy on phonological awareness and decoding</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement seen in phoneme‒grapheme mapping, segmentation and short vowel identification. Some improvement in decoding </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing 1 × per week sessions from 6.0 to 11.6 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lack of experimental control, multiple baselines or control data. CAS diagnosis unclear and not replicable. No statistical analysis. Limited outcome measures.<br/> No blinding of assessors. No follow‐up or generalisation data. No replication across participants. Difficult to replicate measures and treatment used </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Participants: All participants are English speakers unless otherwise reported.</p> <p><b>AOS</b> : apraxia of speech; <b>BBTOP</b> : Bankson‐Bernthal Test of Phonology; <b>CAS</b> : childhood apraxia of speech; <b>CSIP</b> : consonant substitute inconsistency percentage; <b>DAS</b> : developmental apraxia of speech; <b>DEAP</b> : Diagnostic Evaluation of Articulation and Phonology; <b>DVD</b> : developmental verbal dyspraxia; <b>GDD</b> : global developmental delay; <b>GFTA‐2</b> : Goldman Fristoe Test of Articulation 2; <b>HCAPP</b> : Hodson Computerized Analysis of Phonological Patterns; <b>ISP</b> : inconsistency severity percentage; <b>KLPA‐2</b> : Khan‐Lewis Phonological Analysis, Second Edition; <b>NARA</b> : Neale Analysis of Reading Ability; <b>PCC</b> : percentage consonants correct; <b>PDD‐NOS</b> : pervasive developmental disorder ‐ not otherwise specified; <b>PMLU</b> : phonological mean length of utterance; <b>PVC</b> : percentage vowels correct; <b>PWC</b> : percentage words correct; <b>PWP</b> : proportion of whole‐word proximity; <b>PIPA</b> : Preschool and Primary Inventory of Phonological Awareness; <b>RCT</b> : randomised control trial; <b>SSD</b> : speech sound disorder; <b>TOCS+</b> : Test of Children's Speech Plus; <b>TOPA</b> : Test of Phonological Awareness; <b>VMPAC</b>: Verbal Motor Production Assessment for Children </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Excluded, low‐quality evidence from observational studies (case‐series, case control)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006278.pub3/full#CD006278-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006278.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006278-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006278-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006278-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006278-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006278-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006278-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006278-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006278-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006278\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006278\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006278\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006278\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006278\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=23LRTUA6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006278.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006278.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006278.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006278.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006278.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717252610"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006278.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717252614"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006278.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db366dfe49365',t:'MTc0MDcxNzI1My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 